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Telomeres, protein-DNA structures that distinguish the end of a chromosome
from a bona fide DNA double strand break, are integral to genomic stability. High
fidelity replication of telomeres is indispensable for their stability. Telomere replication
is a challenging task that is completed through the coordinated actions of telomere
binding proteins and DNA replication and repair proteins in ways that are not well
understood. This work focuses on delineating the function of one DNA replication and
repair protein, Flap Endonulcease 1 (FEN1), in telomere replication and maintenance. I
demonstrate that FEN1 is essential for the efficient replication of telomeres through its
ability to re-initiate stalled replication forks.

FEN1 depletion leads to telomere

dysfunction characterized by the recognition of the telomeres as DNA double strand
breaks and the specific loss of telomeres replicated by the lagging strand machinery.
Expression of catalytically active telomerase, the reverse transcriptase that adds telomeric
repeats to chromosome ends, was sufficient to rescue telomere dysfunction upon FEN1
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depletion. Genetic rescue experiments revealed that the nuclease activity of FEN1, its
interaction with the RecQ helicases and its ability to process DNA bubble structures are
essential to prevent telomere loss, whereas its ability to process Okazaki fragments is
dispensable. However, FEN1 depletion did not affect cell cycle progression or in vitro
DNA replication through non-telomeric substrates and in the absence of telomere
dysfunction, FEN1 depletion did not affect overall genomic stability. Further analysis
revealed that FEN1 is important for the efficient re-initiation of stalled replication forks
and that this function ensures telomere stability. As with telomere loss, FEN1’s ability to
process bubble DNA structures and its ability to interact with the RecQ helicases are vital
for the re-initiation of stalled replication forks. Finally, FEN1 depletion in transformed
telomerase-negative ALT-positive cells leads to telomere end-to-end fusions. I propose
that FEN1 maintains stable telomeres through the efficient re-initiation of stalled
replication forks that occur in the G-rich lagging strand telomere, ensuring high fidelity
telomere replication.

This model suggests that mutations that arise in FEN1 are

detrimental to telomere stability, leading to genomic instability and driving the
transformation process.

iii

Acknowledgments
I would like to thank Sheila for taking me under her wing as her first graduate
student. She patiently molded me into a better graduate student and provided invaluable
mentorship throughout my time here. She has been very supportive through difficult
times and developed a lab with substantial personality that made my time here fun. I
have learnt a tremendous amount from her, about life as both a scientist and as a
‘marine’.

The lab itself has been my home away from home for the past few years. I want
to thank all the past and present members for their help, invaluable discussions and
scientific insights that together have made me a better critical thinker. Lionel pushed me
to question everything with his cynical humor; Cynthia, apart from her sunny disposition,
made the lab run like a well-oiled machine; Josh provided an excellent sounding board;
Mira made our lunches and post-five p.m. conversations entertaining; Julien’s constant
pranks livened up the lab; Xianmin always made sure that I ate well with her tasty
dumplings; Kelly made a great bay-mate and provided endless entertainment; Ben always
provided me with a good laugh and good music, a fantastic combination; and Daniel
shared my work load in the past few months, making them go smoothly.

My parents have been incredibly supportive towards my education. I would like
to thank them for sending me to boarding school so that I could become independent, for
letting me pursue science and allowing me to break away from the family tradition, for

iv

sending me to the US to get the best education here, and for providing me with all the
support, emotionally and financially, through my time here. I would also like to thank
my siblings without whose support I would never have been able to pursue any of these
dreams.

I would like to thank all my friends at the DBBS and in St. Louis who have made
my time here a rewarding experience.

The ‘superfriends’ of the “Delta Beta Beta

Sigma”, the past and present members of 21 North Taylor, the MPOs group, all the
Frisbee players and the Wildflower crew have all made my time here pass by quicker and
provided much needed therapy. Thank you Drew and Kelly for keeping me running and
motivated; Jim and Melanie for making life smoother for me; Monica and Ericka for their
beautiful friendship, ‘sumo-wrestling’ and dancing and for being the incredible support
network that you have been; Durga and Venny for being my St. Louis family, for being
my sanity and for keeping me well fed. I would like to thank Tejas Kalastavadi for being
the best friend and roommate I could have asked for during my time here. My experience
in St. Louis would not have been the same without our countless beers, the hours of late
night discussions and this friendship.

I would finally like to thank my thesis committee for providing guidance and
direction to this project.

v

Table of Contents
Abstract of the Dissertation
Acknowledgments
Table of Contents
List of Tables and Figures

ii
iv
vi
viii

CHAPTER 1: BACKGROUND AND SIGNIFICANCE

1

1.1 SIGNIFICANCE AND OVERVIEW
1.2 TELOMERES AND CANCER: THE TELOMERE HYPOTHESIS
1.3 TELOMERE STRUCTURE AND FUNCTION
1.4 TELOMERE REPLICATION
1.5 CHALLENGES TO TELOMERE REPLICATION
1.6 FLAP ENDONUCLEASE 1 AND TELOMERE REPLICATION
1.7 SUMMARY
REFERENCES

2
2
5
9
11
14
19
25

CHAPTER 2: FLAP ENDONUCLEASE 1 CONTRIBUTES
TO TELOMERE STABILITY

37

ABSTRACT
RESULTS AND DISCUSSION
MATERIALS AND METHODS
ACKNOWLEDGMENTS
REFERENCES

38
38
46
50
62

CHAPTER 3: FEN1 ENSURES TELOMERE STABILITY
BY FACILITATING DNA REPLICATION FORK REINITIATION
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
FEN1 depletion leads to inefficient replication fork restart
FEN1 depletion does not impact S phase progression
FEN1 depletion does not impact DNA replication kinetics in vitro
FEN1 interacts with the Shelterin component, TRF2
FEN1 promotes telomere stability by facilitating DNA replication
fork re-initiation
DISCUSSION
vi

66
67
68
71
75
75
81
82
83
84
87

ACKNOWLEDGMENTS
REFERENCES

91
101

CHAPTER 4: FEN1 CONTRIBUTES TO TELOMERE
STABILITY IN ALT-POSITIVE TUMOR CELLS
ABSTRACT
RESULTS AND DISCUSSION
FEN1 is required for telomere stability in ALT cells
FEN1 depletion in telomerase positive cells does not impact
telomere stability
Catalytically active telomerase rescues FEN1 depletion at the
telomeres
ACKNOWLEDGMENTS
REFERENCES

CHAPTER 5: CONCLUSIONS AND FUTURE
DIRECTIONS
5.1 SUMMARY
5.2 FEN1 IN DNA REPLICATION AND REPAIR
5.3 TELOMERE REPLICATION: FEN1 AT THE ENDS
5.4 FEN1, TRF2 AND THE RECQ HELICASES, BLM AND WRN
5.5 FEN1: A TUMOR SUPPRESSOR
5.6 CONCLUSIONS
REFERENCES

vii

107
108
108
110
113
113
117
123

126
127
128
131
134
136
138
140

List of Tables and Figures
CHAPTER 1: BACKGROUND AND SIGNIFICANCE
Figure 1.1 The telomere hypothesis
Figure 1.2 Schematic of the T-loop and telomere structure
Figure 1.3 Telomere stability requires DNA damage response proteins
Figure 1.4 Telomere replication is a challenging task

21
22
23
24

CHAPTER 2: FLAP ENDONUCLEASE 1 CONTRIBUTES
TO TELOMERE STABILITY
Figure 2.1 FEN1 depletion leads to telomere dysfunction
Figure 2.2 Increased sister telomere loss (STL) upon FEN1 depletion
Figure 2.3 FEN1 depletion leads to loss of telomeres replicated by
lagging strand DNA synthesis
Figure 2.4 The nuclease activity and C-terminal region of FEN1 are
essential for its role at the telomere
Figure 2.S1 FEN1 localizes to the telomere
Figure 2.S2 FEN1 localizes to the telomere
Figure 2.S3 FEN1 interacts with TRF2
Figure 2.S4 Schematic representation of the pResQ vector
Figure 2.S5 The nuclease activity and C-terminal region of FEN1 are
essential for its role at the telomere
Table 2.S1 Cytogenetic analysis upon FEN1 depletion in the absence
(BJL) and presence of telomerase (BJLT)

52
53
54
55
56
57
58
59
60
61

CHAPTER 3: FEN1 ENSURES TELOMERE STABILITY
BY FACILITATING DNA REPLICATION FORK REINITIATION
Figure 3.1 FEN1 depletion decreases re-initiation of stalled replication
forks
Figure 3.2 The gap endonuclease activity and C-terminal of FEN1 are
essential to re-initiate stalled replication forks
Figure 3.3 FEN1 depletion does not affect S-phase progression and in
vitro DNA replication
Figure 3.4 FEN1 mutants interact with TRF2 and localize to the
telomere
Figure 3.5 The gap endonuclease activity of FEN1 is essential for its
function at the telomere

viii

92
94
96
98
99

CHAPTER 4: FEN1 CONTRIBUTES TO TELOMERE
STABILITY IN ALT-POSITIVE TUMOR CELLS
Figure 4.1 FEN1 depletion leads to telomere dysfunction in ALT cells
Figure 4.2 FEN1 is not essential for telomere stability in telomerase
positive cells
Figure 4.3 Catalytically active telomerase rescues telomere instability
upon FEN1 depletion

ix

118
120
121

CHAPTER 1:
BACKGROUND AND SIGNIFICANCE

1

1.1 Significance and Overview
Normal human cells possess a limited replicative lifespan. These cells enter a
state of permanent cell cycle arrest termed senescence [1]. Cells possess an internal
mitotic clock, identified as the telomere, capable of limiting their potential for cell
division [1-3]. Work since then has demonstrated that telomeres can function as tumor
suppressors in the face of intact checkpoints, promote tumorigenesis through the
induction of genomic instability and are essential for cellular immortality, a defining
characteristic of tumor cells [4]. The realization that the telomere plays a pivotal role in
the transformation process led researchers to focus on the biochemical mechanisms that
govern its stability. What has emerged from this work is an understanding that telomere
maintenance is the result of the coordinated actions of telomere binding proteins and the
DNA replication and repair machinery. Delineating how these mechanisms interact and
how the DNA repair machinery differentiates between the telomere and a bona fide DNA
double strand break is a current challenge.

1.2 Telomeres and Cancer: The Telomere Hypothesis
In 1961, Leonard Hayflick observed that fibroblasts isolated from an individual
underwent a limited number of cell divisions (later referred to as the ‘The Hayflick
limit’), at which point they underwent a checkpoint-dependent permanent growth arrest
termed senescence [5, 6]. These observations led to the hypothesis that the cell contained
an internal clocking mechanism that counted the number of cellular divisions. The
realization that the telomere was the long sought after internal clocking mechanism came
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much later in 1990s. In the 1970s, James Watson and Alexey Olovnikov had proposed
the “end replication problem”, suggesting that due to the inherent nature of lagging strand
DNA replication, the termini of linear chromosomes would not be completely replicated
leading to the loss of genetic material with every cell division [7, 8]. Harley and Greider
eventually demonstrated the connection between the end replication problem and the
Hayflick limit, postulating that the internal clocking mechanism was the telomere [2].
They demonstrated that the mean telomere length of normal human cells shortened
progressively with each cell division and that telomere length predicted the replicative
capacity of cells [2, 3]. Importantly, when cells were isolated from the same individual
on multiple occasions, they entered senescence with similar kinetics and with
approximately the same telomere length, suggesting that telomere length was responsible
for triggering senescence [3]. These observations gave rise to the “telomere hypothesis”,
which suggested that telomeres represent the internal clocking mechanisms originally
described by Hayflick [2, 9]. Indeed, it is now appreciated that senescence can be
triggered by loss of telomere structural integrity and that telomere length is one
component that contributes to this integrity [9-11]. Additionally, senescence can also be
induced through other telomere-independent mechanisms such as environmental and
oncogenic stress and DNA damage [12].

The telomere hypothesis, describing the mitotic clock, postulates that the loss of
telomeric DNA due to incomplete end replication leads to cellular senescence, the first
proliferative barrier (Figure 1.1). Telomere-induced senescence is a critical tumor
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suppressor mechanism in vivo, forming a barrier to cellular immortalization [13-19].
Inactivation of both the p53 and Rb tumor suppressor pathways allows the bypass of
senescence in human cells, leading to continued cell division and further telomere
shortening [9, 20]. Cells that bypass senescence eventually reach a second proliferative
barrier referred to as crisis (Figure 1.1). At crisis, telomere lengths are critically short
leading to structural destabilization, chromosomal end-to-end fusions, and subsequent
cell death [9]. Cells that continue to divide despite the loss of telomere integrity undergo
chromosome breakage-fusion-bridge cycles, develop chromosomal aberrations and
genomic instability, a driving force in the evolution of a human tumor cell [21, 22].

Approximately 1 in 107 cells entering crisis escape death. Those that do escape
crisis activate a telomere maintenance mechanism and thus acquire immortality (Figure
1.1), a defining characteristic of human tumors [23]. The majority of cells activate
telomerase (hTERT) – a reverse transcriptase that utilizes an RNA template to add de
novo telomeric sequences to the ends of telomeres [24-26]– which lengthens the
telomeres and allows the formation of a stable telomere structure [27, 28]. The ability of
telomerase to immortalize cells and its necessity in the transformation process suggested
that inhibition of telomerase would diminish the proliferative capacity of cancer cells.
Indeed, telomerase inhibition in telomerase-positive immortal tumor cells led to
progressive telomere loss and the induction of apoptosis [29] (Figure 1.1). It also led to
loss of tumorigenic potential in xenograft models indicating the necessity of cellular
immortality for tumorigenesis [29].
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Alternatively, cells can utilize a non-telomerase based method for stabilizing and
lengthening their telomeres, known as ‘ALT’ (Alternative Lengthening of Telomeres)
[30, 31]. Unlike telomerase which utilizes an RNA component to add telomeric repeats
to chromosomes ends, the ALT mechanism is postulated to utilize homologous
recombination (HR) to lengthen telomeres [31-34], though the molecular details of this
mechanism still require elucidation. Together, these studies underscore the importance of
telomeres at different stages in the transformation process and signify the importance of
understanding mechanisms that govern its stability.

1.3 Telomere structure and function
Since Barbara McClintock and Herman Muller first identified them in the 1930s,
telomeres have been recognized as capping structures that play an essential role in
distinguishing natural chromosome ends from bona fide DNA DNA double strand breaks
(DSBs) [35, 36]. When telomeres become critically short their protective structure is
compromised, triggering a DNA damage response (DDR) [37].

These unprotected

telomere ends are recognized as DSBs, established by the presence of several DNA DSB
response factors such as phosphorylated-ATM (ataxia-telangiectasia mutated), γ-H2AX,
MDC1, NBS1 and 53BP1 [37]. Such DNA damage foci at the telomeres were named
telomere dysfunction-induced foci (TIFs) [38]. Recent work has clearly demonstrated
that the ability to maintain telomere structure is dependent on the length of the telomere,
presence of the ssOH and a plethora of proteins that bind and/or modify the telomere [39,
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40]. While it was originally believed that the telomere must exclude DDR proteins to
maintain its stability, it is now clear that such machinery plays an integral role in
telomere maintenance [41]. The current challenge is to define the mechanisms that
govern the actions of the DDR machinery that leads to the formation of a stable capped
telomere versus those that act upon uncapped (i.e. dysfunctional) telomeres.

The telomere is a dynamic nucleoprotein structure (Figure 1.2).

It forms a

complex displacement loop (D-loop) structure, referred to as the “T-loop”, where the
single strand overhang loops back around and inserts itself into the double strand region
of the telomere (Figure 1.2). The T-loop structure was visualized both in vitro and in
vivo through electron microscopy [42, 43]. It is suggested that this ‘capped’ telomere
hides the end of the chromosome and prevents its recognition by the DNA damage
pathway. The stability of the T-loop is dependent on the presence of the ssOH as well as
TRF2, an essential telomere binding protein [40, 44]. It is therefore interesting to note
that the length of the ssOH is significantly shorter in senescent cells compared to younger
cells [45], suggesting that the telomere structure is disrupted in senescent cells.

In addition to TRF2, other proteins are important for telomere maintenance.
Many of these proteins have been characterized, including a core complex of six proteins
referred to as Shelterin [40, 46], consisting of TRF1, TRF2, TIN2, TPP1, POT1 and
RAP1 (Figure 1.2).

TRF1 and TRF2 coat the length of the telomere as homodimers

with high specificity to telomere double-strand DNA [47-51]. TIN2 binds to both TRF1
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and TRF2 forming a protein ‘bridge’ between these two proteins [52-54]. POT1 binds to
single strand telomeric DNA via an OB (oligonucleotide binding)-fold domain, while
TPP1 has been shown to recruit POT1 to the telomere [55, 56]. TPP1 also links POT1 to
TIN2, and therefore forms a bridge to the TRF1 and TRF2 proteins. RAP1 is recruited to
the telomere by TRF2 [57, 58]. All the above-mentioned proteins are required for the
maintenance of a functional telomere. Disturbing the equilibrium of these proteins by
either overexpression or depletion results in telomere dysfunction [40]. For example,
depletion of TRF2 or introduction of a TRF2 dominant-negative allele results in telomere
destabilization or uncapping, recognition as a DNA DSB, and formation of TIFs,
characterized by the presence of 53BP1 and γH2AX at the telomere [37, 38, 59]. The cell
attempts to repair these lesions via non-homologous end joining (NHEJ) or single-strand
annealing, leading to chromosome end-to-end fusions with telomeric DNA at the
junctions [60, 61].

The Shelterin components perform several essential tasks that maintain stable
telomeres [40]. In addition to maintaining telomere structure, TRF2 is an inhibitor of
ATM and Chk2 at the telomere [62, 63], suggesting that the ATM pathway is spatially
controlled at the telomere. The other Shelterin components also influence telomere
dynamics when their levels are modulated. For example, overexpression of TRF1 results
in telomere shortening both in telomerase-positive human and mouse cells, suggesting
that TRF1 controls telomerase access to chromosome ends [49]. Recent work has also
demonstrated that TRF1 is essential for telomere replication and that its absence leads to
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the formation of stalled replication forks at telomeres [64]. POT1 functions to maintain
telomere length by modulating the action of telomerase and protects their stability by
inhibiting the action of the ataxia-telangiectasia and Rad3-related (ATR) pathway [62,
65, 66]. TIN2 and TPP1 do not bind telomeric DNA directly, but influence telomere
dynamics by forming a protein bridge between the double strand DNA binding proteins
TRF1 and TRF2 and the single strand DNA binding protein POT1 [54, 67]. The loss of
either protein leads to the activation of DDR at telomeres and the formation of TIFs [40].
Recently, a novel form of TIN2 has also been identified at the nuclear matrix, suggesting
a unique role for it in anchoring telomeres [68]. TPP1 interacts directly with POT1 and is
involved in the recruitment of telomerase to the telomeres [67]. Finally, RAP1 interacts
directly with TRF2 and this complex inhibits nonhomologous end-joining repair proteins
from recognizing the telomere as a DSB [69].

In addition to the core Shelterin complex, a number of DDR proteins have been
associated with the telomere (Figure 1.2). The functional importance of the DDR
proteins at the telomere was first observed in Saccharomyces cereviseae (S. cereviseae),
where cells with mutations in TEL1, an Ataxia Telangiectasia Mutated (ATM) homolog,
resulted in shortened telomeres [70, 71]. This was further confirmed by studies in
Schizosaccharomyces pombe (S. pombe), mice and human cells [72]. Similarly, several
proteins involved in DNA replication, DNA damage signaling and DNA repair play
critical roles in telomere maintenance.

These include DNA damage signaling

phosphoinositide 3-kinase related kinases (PIKKs) such as ATM, ATR and DNA-PK [73,
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74]; homologous recombination machinery such as RAD54, RAD51D, the MRN
complex (comprising the Mre11, Rad50 and NBS1 proteins) and BRCA1 [75-77];
proteins involved in non-homologous end joining such as KU70/KU86 [73, 78]. Several
base excision repair proteins also play an important role in telomere biology such as the
XPF/ERCC1 complex, PARP1 and PARP2 proteins [79-84]. A recent study also
identified Apollo, a nuclease that plays a specific role in telomere biology [85, 86].
Furthermore, the Werner (WRN) protein, a RecQ helicase that functions in
recombination and repair pathways, is essential to ensure high fidelity replication of the
lagging strand at the telomere [87, 88]. Finally, the Origin recognition complex (Orc2)
localizes to the telomere where it prevents telomere loss and the formation of telomeric
circles – a hallmark of telomere replication stress [89]. All the above examples illustrate
the intricate relationship between the DNA replication and repair factors and telomere
maintenance; however, a comprehensive understanding of this interplay has yet to be
elucidated.

The work discussed in this thesis takes our understanding further by

characterizing the function of Flap Endonuclease 1 (FEN1), a DDR factor, at human
telomeres.

1.4 Telomere replication
Continued cellular proliferation requires high fidelity duplication of the genome
and proper maintenance of the telomeres. Loss of genomic integrity contributes to the
transformation process, therefore several compensatory mechanisms have evolved to
ensure high fidelity replication of the genome. Highly repetitive sequences, such as the
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telomere, present unique challenges to the DNA replication machinery making them
exquisitely sensitive to the loss of repair and replication mechanisms [90, 91].

As

detailed above, several DNA replication and repair proteins bind telomeres, interact with
Shelterin proteins and are critical for telomere function [40]. Depletion of these proteins
or abrogation of their telomere binding capability leads to telomere dysfunction,
indicating that these proteins play a specific role in maintaining telomere stability. Based
on these observations, I hypothesize that replication of this specialized structure – the
telomere – requires a coordinated effort by the telomere binding proteins and the DNA
replication and repair proteins. Several questions arise from this hypothesis – Which are
the telomere binding proteins involved? Which are the DNA replication and repair
proteins involved? Are the telomere-binding proteins actively involved in telomere
replication and repair or do they simply provide a scaffold? Do the telomere binding
proteins modulate the activity of the DNA replication and repair machinery? How is this
process regulated and coordinated? Several lines of evidence have recently emerged
supporting the stated hypothesis [64, 89-92]. Indeed, Shelterin components, TRF1 and
TRF2 interact with and modulate the activities of several DNA repair and replication
proteins [40]. These findings have led to a new model of telomere function: once thought
to exclude the DNA repair machinery it is now appreciated that telomere replication and
stability is the result of an intricate interplay between the telomere binding proteins and
the DNA replication and repair mechanisms (Figure 1.3).
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1.5 Challenges to telomere replication
Replication of telomeres poses several challenges to the moving fork (Figure
1.4).

Telomeric repetitive G-rich sequences have a high propensity to form G-

quadruplexes (G4) that impede the progressing replication fork, leading to the formation
of stalled forks [90, 93, 94]. Indeed, several reports have indicated pausing and/or
stalling of replication forks moving through telomeres [95-97]. The presence of the Tloop also presents a topological barrier for the replication fork. Additionally, telomere
replication is primarily initiated by the most distal origin of replication from the
centromere and continues unidirectionally towards the end of the telomere (Figure 1.4)
[64]. If this fork stalls and is not re-initiated efficiently, it will collapse leading to the
formation of a DSB [98] resulting in telomere deletion. Therefore it is not surprising that
telomeres have been recently identified as fragile sites that are highly sensitive to
replication stress [64].

As a result, successful telomere replication requires the

coordinated action of telomere binding proteins and their recruitment and/or modification
of traditional DNA replication and repair factors [90, 91].

Recent work indicates that stalled forks are formed within replicating human
telomeres [97]. During S-phase the ATR-dependent DDR machinery (ATR and RPA) is
recruited together with the DNA replication machinery (Pol α, PCNA, FEN1) [97] to the
telomere.

The ATR-dependent repair machinery is postulated to be present at the

telomere in response to stalled replication forks, resolving them and leading to efficient
telomere replication. In addition, the T-loop has to be resolved to allow the passage of
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the replication fork and reformed post duplication, to form a stable telomere structure. In
late S/early G2 phase of the cell cycle, phosphorylated ATM and the HR machinery are
recruited to the telomere [97, 99], suggesting that these proteins are involved in the reformation of the T-loop. Together, these observations indicate the presence of stalled
replication forks at human telomeres and reveal a critical role for the DNA replication
and repair machinery to efficiently duplicate telomeres.

Robust mechanisms evolved to ensure high fidelity replication and repair of the
telomere appear to be coordinated by telomere binding proteins [90, 91]. Work done in
S. pombe demonstrated that Taz1 (the TRF1 and TRF2 homolog) is required for efficient
replication fork progression through the telomere [92]. Taz1 loss causes progressing
replication forks to stall upon encountering telomere sequences, resulting in a lack of
telomere replication and an abrupt, complete loss of telomeres.

Importantly, Taz1

requirement for telomere replication occurs due to the sequence of the telomere itself,
independent of its location in the genome [92]. This was the first evidence suggesting
that telomere replication is dependent on telomere-binding proteins.

Similar work in mammalian cells demonstrated that TRF1 is critical for telomere
replication [64]. Deletion of TRF1 resulted in an increase in stalled replication forks at
telomeres, decreased telomere replication and activation of the ATR-dependent DDR
[64].

The report concluded that telomeres resemble fragile sites and that TRF1 is

required for efficient replication primarily through its recruitment of the BLM and
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RTEL1 helicases [64]. The requirement of TRF1 for efficient telomere replication is
analogous to Taz1.

Recent work also supports the putative role of TRF2 in coordinating the activities
of DDR proteins at the telomere. TRF2 binds and initiates the replication of the oriP
sequence in the Epstein Barr virus DNA [100]. In addition, TRF2 directly interacts with
ORC2, a central component of the origin of replication complex that binds replication
origins and initiates bidirectional DNA replication [100]. Interestingly, loss of ORC2
leads to telomere dysfunction, characterized by signal free ends and the appearance of
circular telomeric DNA (T-circles), suggesting inefficient telomere replication [89].
Further work demonstrated that deletion of the region of TRF2 that interacts with ORC2
also leads to the formation of T-circles suggesting that this interaction is important for
efficient telomere replication, and that TRF2 indeed coordinates telomere replication
[101].

In addition to the G-rich sequence, the T-loop also presents a barrier to telomere
replication (Figure 1.4). Indeed, as a replication fork approaches the distal end of the
telomere, the T-loop is likely to inhibit free rotation of the DNA, thus posing a
topological barrier to the replication machinery. To allow passage of the replication fork,
the T-loop needs to be resolved by the actions of specialized helicases. Post duplication
of the DNA, the T-loop needs to be reformed by the HR machinery to ensure a stable
telomere. Several lines of evidence suggest that the resolution and reformation of the T-
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loop are also coordinated by telomere binding proteins such as TRF1 and TRF2. Both
TRF1 and TRF2 interact with and stimulate the activities of the WRN and BLM RecQ
helicases that are able to assist in the resolution of D-loop structures [102, 103]. In
addition, TRF1 and TRF2 are integral to T-loop re-formation as well [97]. Indeed, it was
recently described that TRF2 can directly enhance strand invasion required for the
formation of the T-loop (Figure 1.2) [104]. Together these results demonstrate that
telomere replication is unique, and requires a coordinated effort from telomere binding
proteins and the DNA replication and repair machinery to efficiently complete
replication.

1.6 Flap Endonuclease 1 and Telomere Replication
The inherent nature of the telomeric DNA sequence causes strand specific DNA
replication – the C-rich strand always provides the template for leading strand synthesis
while the G-rich strand is the template for lagging strand replication (Figure 1.4). The
repetitive nature of the telomeric DNA and the tendency of G-rich DNA to form
secondary structures create a situation in which lagging strand replication at the telomere
is particularly challenging. Therefore, several studies have focused on understanding the
role of lagging strand replication proteins in telomere maintenance [105-107].

Lagging strand DNA synthesis requires the formation and processing of Okazaki
fragments, which need to be cleaved and ligated (known as Okazaki fragment
maturation) [108, 109].

One model of Okazaki fragment maturation suggests that
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maturation requires the coordinated activity of two nucleases, FEN1 and Dna2 [109].
This model proposes that upon encountering the RNA/DNA strand from the adjacent
Okazaki fragment, polymerase δ displaces the strand producing a flap structure. If the
flap is long or forms a secondary structure it is coated by RPA initiating its cleavage by
Dna2 into a shorter flap, which is then processed by FEN1 to generate a nick sealed by
DNA ligase I [110].

FEN1 is a structure-specific metallonuclease that plays an important role in DNA
metabolism. In addition to Okazaki fragment processing, FEN1 is also a critical DNA
repair enzyme. Work done in S. cerevisiae, S. pombe and human cells demonstrate that
FEN1 and its homologs are also involved in long-patch base-excision repair (LP-BER)
[111, 112]. Indeed, deletion of FEN1 homologs in S. cerevisiae and S. pombe leads to
UV sensitivity indicating a role for FEN1 in BER [113-115]. Yeast rad27Δ (the FEN1
homolog) mutants and human carcinoma cells expressing a dominant negative FEN1
protein are also sensitive to the DNA alkylating agents such as methylmethane sulfonate
(MMS) [114, 116]. Additionally, genetic work in yeast and chicken cells has suggested
that FEN1 is involved in NHEJ and homologous recombination pathways [117-119].
Defects and deletions of FEN1 in yeast also lead to an increase in spontaneous mutations
[113, 114]. Besides its role in DNA replication and repair of genomic DNA, recent work
indicates that FEN1 activity is important in mitochondrial DNA repair [120].
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FEN1 also prevents trinucleotide repeat (TNR) expansion and contraction [111,
118, 121]. Work in yeast shows that deletion or haploinsufficiency of RAD27 leads to
expansion of triplet repeats presumably due to strand slippage and/or formation of
secondary structures that cannot be processed by FEN1 [122]. Similarly, in mice
haploinsufficiency of FEN1 leads to the expansion of a Huntington’s disease locus CAG
repeat [118]. However, recent studies have shown that TNR expansion upon FEN1 loss
is a species-specific phenomenon. Mutation of FEN1 in Drosophila did not affect the
CAG repeat locus [123]. Similarly, FEN1 depletion in human cells that were cultured
over 27 successive passages did not affect the CAG Huntington’s locus stability [124].
Despite clear species differences, these results demonstrate the importance of FEN1 in
DNA replication, DNA repair and maintenance of genome stability.

FEN1 has multiple nuclease activities [111, 125]. It has a 5’ flap endonuclease
(FEN) activity and a 5’ to 3’ exonuclease (EXO) activity, both of which have been
studied extensively [115, 126]. These two activities are considered crucial for Okazaki
fragment maturation and long patch–base excision repair. Recently, human FEN1 was
also found to cleave gapped DNA forks or bubble structures that resemble stalled
replication forks [127, 128]. Mutational analysis enabled the separation of this gap
endonuclease (GEN) activity from the FEN and EXO activities. Interestingly, the GEN
activity did not require a free 5’ flap like the FEN and EXO activities and it has since
been implicated in apoptotic DNA fragmentation and reinitiation of stalled replication
forks [127, 129, 130].
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The multiple FEN1 nuclease functions and DNA replication and repair activities
suggests differential regulation of these through post-translational modification. Indeed,
FEN1 is phosphorylated by Cdk1-Cyclin A in late S phase [131], which reduces its FEN
and EXO activities without affecting its DNA binding capabilities.

In addition,

phosphorylation abolishes PCNA binding, suggesting that it is able to regulate FEN1
function in DNA replication and repair [131]. FEN1 is also acetylated by p300 histone
acetyl transferase (HAT) at four lysine residues on the C-terminus [132]. Acetylation of
FEN1 is induced by UV treatment and reduces its DNA binding capability as well as its
FEN and EXO nuclease activities [132], indicating a role for it in DNA repair. Although
these post-translational modifications suggest a functional modulation of FEN1 activity,
their biological significance has yet to be elucidated.

Given FEN1’s role in genome maintenance, it is not surprising that it is an
important tumor suppressor [133].

Homozygous deletion of FEN1 in mice is inviable,

whereas the heterozygous animals are viable and disease-free [134, 135]. However, in a
heterozygous adenomatous polyposis coli (APC) background, the haploinsufficiency of
FEN1 leads to adenocarcinomas in the gastrointestinal tract and decreased survival of the
mice [134, 136].

The biological relevance of FEN1 is further underscored by the

discovery of mutations in human FEN1 that have been implicated in increased
tumorigenesis [130, 137].

Analysis of several tumor types from lung, breast and

melonoma revealed point mutants that abrogated two of the three known FEN1 functions
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[130]. Interestingly, these mutations affected the GEN activity of FEN1, leaving the FEN
activity intact. Knocking in one of these FEN1 mutations, E160D, in mice led to the
development of autoimmunity and neoplasias in the lung [130]. This was attributed to
incomplete DNA fragmentation during apoptosis due to decreased GEN activity.
Another study conducted on a different strain of mice with the same point mutation in
FEN1 revealed a different spectrum of cancers with early B-cell lymphomas [138].
Comparative genomic hybridization analyses of these lymphomas showed genomic
instability with changes in chromosome copy number, chromosomal rearrangements,
gains and losses [138].

Finally, Rad27, the FEN1 homolog in S.cerevisease, plays an important role in
telomere function [105, 106]. Indeed, deletion of RAD27 led to heterogeneous telomere
lengths and an increase in single strand telomeric overhang (ssOH). The increase in
ssOH is attributed to incomplete or defective lagging strand synthesis at the telomeres
[105, 106]. Similarly, deletion of Rad2, the FEN1 homolog in S. pombe, led to telomere
shortening [139]. Together these results demonstrate that FEN1 is important for telomere
maintenance in lower eukaryotes, suggesting a role for FEN1 at mammalian telomeres.

Indeed, work on mammalian FEN1 also supports a role for this protein in
telomere maintenance. FEN1 physically interacts with WRN [140], a RecQ helicase that
plays an important role in lagging strand DNA replication at the telomere [87]. This
interaction stimulates both the FEN and the GEN activities of FEN1 [127, 140],
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suggesting a role for this complex in DNA repair and replication. Interestingly, FEN1
and WRN form a complex upon encountering stalled replication forks and processes
branch migrating structures resembling regressed forks in vitro [141]. Importantly, the
Shelterin component, TRF2 also interacts with FEN1 [142], suggesting that it recruits
FEN1 to the telomere for accurate processing of telomeric DNA. Finally, recent work
demonstrated that FEN1 associates with mammalian telomeres in a biphasic manner,
localizing to the telomere during the S and G2 phases of the cell cycle [97], suggesting a
role for FEN1 in mammalian telomere replication and repair.

1.7 Summary
Elucidating the different components involved in the efficient replication and
maintenance of stable telomeres is paramount to our understanding of these complicated
structures that play a pivotal role in tumorigenesis. The complex nature of the telomere
presents a uniquely challenging template for the DNA replication machinery, making
coordination between telomere binding proteins and DNA replication and repair
machinery vital to successful telomere replication. Several lines of evidence suggest that
FEN1, an important nuclease in DNA replication and repair, is a bona fide telomere
binding protein that has a role in mammalian telomere biology. The following sections
of this thesis will elucidate the role of FEN1 in maintaining and preserving telomere
stability. Chapter 2 focuses on the role of FEN1 in replicating mammalian telomeres in
primary human fibroblasts that do not have an active telomere maintenance mechanism.
Chapter 3 concentrates on elucidating the mechanism through which FEN1 is able to
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efficiently replicate human telomeres in primary human fibroblasts. Chapter 4 examines
the necessity of FEN1 in the maintenance of stable telomeres in human tumor cells that
have two different methods of telomere maintenance.

In Chapter 5 I highlight the

significance of this work in advancing our understanding of telomere replication and
draw attention to questions that remain to be addressed from this work.
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Figure 1.1 The telomere hypothesis
Telomere length is progressively lost during successive rounds of cellular division,
eventually leading to p53- and Rb-dependent permanent growth arrest, referred to as
senescence. Inactivation of p53 and Rb pathways allows continued cellular division and
further telomere shortening. Continued telomere erosion leads the cells into their second
proliferative barrier, crisis, where the telomeres are unable to protect the chromosome
ends, resulting in chromosome fusions and cell death. Rare clones escape crisis by
activating a telomere maintenance mechanism, either through the expression of
telomerase or alternative lengthening of telomeres (ALT). Inhibition of telomerase leads
to cell death in telomerase-positive cells.
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Figure 1.2 Schematic of the T-loop and telomere structure
Representation of the T-loop, in which the single-stranded overhang inserts into the
double-stranded telomeric DNA, creating a displacement loop. The DNA and associated
telomeric proteins create a capped, or functional, telomere.
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Figure 1.3 Telomere stability requires DNA damage response proteins
Telomeres were once thought to exclude DNA repair and replication machinery but are
now known to recruit and modulate the activities of this machinery. Failure to recruit
this machinery leads to telomere dysfunction and subsequent genomic instability.
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Figure 1.4 Telomere replication is a challenging task
Replication of telomeres inherently poses several challenges. The telomeric DNA
consists of a highly repetitive G-rich sequence (1) that has a greater probability of
forming secondary structures such as G-quadruplexes (2). The T-loop also presents a
topological barrier to telomere replication (3). Telomeres replicate from a single
unidirectional fork (4) and remain unreplicated if this fork collapses.
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Abstract
Telomere stability plays an important role in the preservation of genomic stability and is
maintained through the coordinated actions of telomere specific proteins and DNA repair
and replication proteins [1, 2]. Flap Endonuclease 1 (FEN1) is a protein that plays a role
in lagging strand DNA replication, base excision repair, homologous recombination, and
re-initiation of stalled replication forks [3, 4]. Here, we demonstrate that FEN1 depletion
leads to telomere dysfunction characterized by the presence of γH2AX and sister
telomere loss. Expression of catalytically active telomerase, the reverse transcriptase that
adds telomeric repeats to chromosome ends, was sufficient to rescue telomere
dysfunction upon FEN1 depletion. Strikingly, FEN1 depletion exclusively abrogates
telomeres replicated by lagging strand DNA replication. Genetic rescue experiments
utilizing FEN1 mutant proteins that retained the ability to localize to telomeric repeats
revealed that FEN1’s nuclease activity and ability to interact with the Werner protein
(WRN) and telomere binding protein, TRF2 were required for FEN1 activity at the
telomere. Given FEN1’s role in lagging strand DNA replication and re-initiation of
stalled replication forks, we propose that FEN1 contributes to telomere stability by
ensuring efficient telomere replication.

Results and Discussion
High fidelity replication of telomeres is critical to maintain telomere stability, and
is confounded by both the end replication problem and repetitive G-rich nature of
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telomeric DNA [5]. Repetitive DNA sequences such as those found in the telomere
present a challenging template for the replication machinery due to a propensity to form
secondary structures that can lead to stalled replication forks [6, 7]. Due to the
importance and difficulty of high fidelity replication through the telomere, recent studies
have focused on the role DNA replication/repair proteins play in telomere stability [811]. Rad27, the FEN1 homolog is one such replication and repair protein that plays a role
at Sachharomyces cerevisiae telomeres [8, 12]. Here, we demonstrate that FEN1 plays a
critical role in mammalian telomere stability.
Previous work demonstrated that FEN1 localized to the telomere in a cell cycle
dependent

manner

[13].

We

confirmed

this

observation

by

chromatin

immunoprecipitation (ChIP) from cells 1) synchronized with thymidine and aphidicolin
(Figure 2.S1) and 2) enriched in different phases of the cell cycle by centrifugal
elutriation (Figure 2.S2).

In agreement with previous work, we found that FEN1

localized to the telomere in the S and G2/M phases of the cell cycle. Purified FEN1 has
been shown to interact directly with TRF2 through both the basic and myb domains of
TRF2 [14]. Utilizing antibodies specific for endogenous FEN1 and TRF2, we
demonstrate that these proteins interact in vivo (Figure 2.S3).
FEN1’s presence at the telomere and its interaction with TRF2 raised the
intriguing possibility that it played a role in telomere biology. To address this directly,
lentiviral expressed RNA interference (RNAi) hairpins targeting FEN1 (shFEN) or a
scrambled hairpin (negative control, shSCR) were introduced into BJ fibroblasts (Figure
2.1A). Upon transduction, FEN1 protein expression was virtually undetectable compared
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to control cells (Figure 2.1B). To determine whether FEN1 depletion resulted in telomere
dysfunction, we analyzed telomeres for the presence of γH2AX (an indicator of DNA
damage) by ChIP. Lysates from cells expressing shSCR or shFEN were subject to
immunoprecipitation using an antibody to γH2AX, followed by quantitation of isolated
telomeric and genomic DNA (ALU).

We found that upon FEN1 depletion,

immunoprecipitation of γH2AX resulted in a significant increase in the amount of
isolated telomeric DNA compared to control cells (1.39 fold greater than control; P<0.05;
Figure 2.1C and 2.1D). In contrast, no significant increase was observed in γH2AX
associated with ALU DNA (1.09 fold; P=0.59), indicating that there is increased DNA
damage upon FEN1 depletion at telomeric sequences compared to the genome at large. A
similar increase in γH2AX associated telomeric and genomic DNA was observed when
cells were treated with the ribonucleotide reductase inhibitor, hydroxyurea (data not
shown). Together these results indicate that FEN1 depletion results in telomere
dysfunction similar to that observed upon replication stress following hydroxyurea
treatment.
We next assessed the telomeres directly upon FEN1 depletion. FEN1 was
depleted in BJ fibroblasts expressing the SV40 early region (BJL) (the presence of the
early region facilitated isolation of metaphase chromosomes) (Figure 2.2A). Following
FEN1 depletion, we utilized fluorescence in situ hybridization (FISH) to visualize
telomeres. We found that FEN1 depletion resulted in increased sister telomere loss (STL)
(Figure 2.2B and 2.2C). On average, 9.4% of the chromosomes isolated from control
cells displayed STLs (Figure 2.2C). Upon FEN1 depletion, the percentage of
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chromosomes displaying STLs increased nearly two-fold (16.8%, P<0.0001; Figure
2.2C), indicating that FEN1 depletion impacted telomere stability.
Depletion of FEN1 leads to sister telomere loss (Figure 2.2) resulting in
recognition of telomeres by the DNA damage machinery (Figure 2.1). Several papers
have demonstrated that telomerase is preferentially recruited to the shortest telomeres
[15-18], raising the possibility that telomerase may compensate for FEN1 depletion at the
telomere. Therefore, we expressed shSCR or shFEN in BJL cells expressing telomerase
(BJLT; Figure 2.2A).

We found that in the presence of telomerase, STLs were

significantly reduced upon FEN1 depletion. Indeed, in BJLT cells only 2.6% of
chromosomes displayed STLs upon FEN1 depletion (P<0.05; Figure 2.2B and C),
which was significantly lower than the 16.8% STLs observed in BJL cells devoid of
telomerase activity. Together, these results demonstrate that telomerase compensates for
FEN1 depletion at the telomere.
The above observation was reminiscent of a report demonstrating that mutations
in WRN, a known FEN1 binding protein, led to STLs that were limited to telomeres
replicated by lagging strand DNA synthesis [19]. Given FEN1’s known role in lagging
strand DNA replication and its interaction with the WRN protein [20, 21], we
investigated whether FEN1 depletion compromised lagging strand DNA synthesis of the
telomere. To carry out these studies, we employed chromosome orientation fluorescent in
situ hybridization (CO-FISH), which is capable of distinguishing between telomeres
replicated by leading versus lagging strand DNA synthesis (Figure 2.3A). CO-FISH
analysis revealed that reduction in FEN1 protein levels led to a specific loss of the
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lagging strand telomere (Figure 2.3B and 3C). BJL cells expressing the control hairpin
(shSCR) had similar levels of telomere loss of both leading and lagging strands (4.4%
and 3.8%, Figure 2.3C). Strikingly, cells expressing shFEN exhibited a significant 2-fold
increase in loss of the lagging strand sister telomeres (9.5% versus 3.8%, P<0.0001;
Figure 2.3C), with no change in the number of leading strand STLs observed. Together,
these data demonstrate that FEN1 depletion exclusively compromises lagging strand
DNA replication at the telomere.
Several biochemical functions have been ascribed to FEN1 [3, 4]. To determine
whether FEN1 nuclease activity or its interaction with the WRN protein is necessary for
telomere stability we created a novel vector, pResQ, capable of expressing both an
shRNA and a cDNA (Figure 2.S4), and conducted genetic rescue experiments. We also
designed a second shRNA targeted to the FEN1 3’ UTR (shFEN3), which facilitated our
analysis by allowing us to deplete endogenous protein, while having no effect on mRNA
produced from a cDNA devoid of the 3’UTR sequence. The FEN1 mutants utilized were
D181A (DA), which completely lacks nuclease activity [22] and delta C (ΔC; 20 amino
acid deletion on the C-terminus), which retains partial ability to process flap structures
with the replication clamp, PCNA, but is unable to bind the WRN protein [23, 24]. Cells
transduced with the indicated vector confirmed that endogenous FEN1 protein was
significantly reduced and the wild-type and mutant proteins were expressed, albeit to
varying levels (Figure 2.4A).
We next determined whether the wildtype or mutant FEN1 proteins could rescue
the telomere dysfunction observed upon FEN1 depletion. No significant change in
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leading strand STLs was observed following expression of any of the FEN1 proteins
(Figure 2.S5 and Figure 2.4B). Reduction of FEN1 protein with a second independent
hairpin (shFEN3) led to a 2-fold increase in lagging strand STLs (Figure 2.4B).
Importantly, expression of wild-type FEN1 (WT) rescued the lagging strand STL
phenotype, indicating that the observed phenotype was specific to the depletion of FEN1
(Figure 2.4B). In contrast, ectopic expression of either the DA nuclease deficient mutant
or the ΔC mutant was unable to rescue the lagging strand STL phenotype upon FEN1
depletion (Figure 2.S5 and Figure 2.4B). These observations suggest that both the
nuclease activity and FEN1’s interaction with WRN is critical for its role at the telomere.
To rule out that failure of the mutants to rescue FEN1 depletion resulted from an
inability of the mutants to interact with TRF2 or localize to the telomere, we conducted
immunoprecipitation and ChIP experiments. As shown in Figure 2.4C, the DA mutant,
but not the ΔC mutant retained the ability to interact with TRF2, indicating that the Cterminal 20 amino acids are critical for FEN1 binding to TRF2. This also suggests that
the phenotype of the ΔC mutant may be compounded by the combined loss of TRF2 and
WRN interactions. To determine whether the mutant FEN1 proteins retained the ability to
localize to the telomere, we also carried out ChIP analysis on lysates from 293T cells
ectopically expressing epitope-tagged proteins. We found that all three FEN1 proteins
associated with telomeric DNA (Figure 2.4D). These results, together with the functional
data presented above, demonstrate that failure to rescue sister telomere loss was not due
to an inability of the mutants to localize to the telomere.

43

FEN1 is a DNA replication and repair protein [4, 25]. To explore the possible
impact of FEN1 depletion on the genome at large, we carried out karyotypic analysis of
BJL and BJLT cells. Upon FEN1 depletion, BJL cells displayed a mild increase in
genomic instability as evidenced by a modest increase in the number of chromatid breaks
and chromosome gaps observed (Table 2.S1). Because telomerase rescues the telomere
phenotype observed upon FEN1 depletion (Figure 2.2), any chromosomal abnormalities
observed in BJLT cells depleted of FEN1 would be attributed to a non-telomeric effect.
Karyotypic analysis of BJLT cells revealed no significant differences between cells
expressing shSCR or shFEN (Table 2.S1), indicating that the impact of FEN1 depletion
on the genome is the result of telomere dysfunction.
FEN1 is a structure specific endonuclease that acts in DNA replication and repair.
Here, we assessed FEN1’s role in telomere stability. In agreement with previous work
[13, 14], we found that FEN1 is present at mammalian telomeres in a cell cycle
dependent manner, and that it interacts with TRF2. This interaction requires the Cterminal region of FEN1. FEN1 depletion led to telomere dysfunction characterized by an
increase in γH2AX at telomeres and sister telomere loss (STL). The latter was repressed
by telomerase expression. CO-FISH analysis revealed that STLs were limited to
telomeres replicated by lagging strand DNA synthesis. We further demonstrated that
FEN1 nuclease activity and its C-terminal region are critical for its function at the
telomere. FEN1 depletion revealed only a mild increase in genomic instability that was
completely abolished in the presence of telomerase. Collectively, these data demonstrate
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that FEN1 is important for telomere stability and suggest that FEN1 is required for
proficient replication and/or repair of telomeres.
Telomere repeat binding proteins interact with DNA replication and repair
proteins to maintain telomere stability [1, 5].

Abrogation of these protein-protein

interactions in both yeast and mammalian systems can have profound effects on telomere
stability [2]. These observations raise the possibility that the telomere represents a
specialized structure whose replication and stability is ensured by the coordinated efforts
of numerous redundant systems [5]. Highly repetitive sequences such as those present in
the telomere can adopt complex secondary structures that are challenging to replicate and
have the potential to lead to stalled replication forks [5, 7]. If left unresolved, these can
result in double strand breaks [26]. Given FEN1’s potential role in the reinitiation of
stalled replication forks [27, 28], its absence is likely to compound the ability of the
replication machinery to successfully transit the G-rich TTAGGG tracks. In support of
this, our data demonstrate that FEN1 depletion results in specific loss of lagging strandreplicating sister telomeres.

We propose that FEN1 is recruited to the telomere to

facilitate replication and in its absence the replication machinery has a propensity to stall
and/or inefficiently re-initiate stalled replication forks within the telomeric repeats. This
hypothesis is particularly attractive in light of work demonstrating that loss of the Werner
protein, which localizes with FEN1 at stalled replication forks thereby facilitating
processing of branch migrating structures [28], phenocopies FEN1 depletion at the
telomere [19]. In both the case of FEN1 depletion (this report) and WRN loss [19],
telomerase rescues the telomere phenotype. Because telomerase is recruited to, and
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extends the shortest telomeres [15-18], its presence would be expected to rescue STLs by
lengthening shortened telomeres created after a stalled-fork-induced break. Interestingly,
the ΔC FEN1 mutant that does not interact with the WRN [24] or TRF2 protein is unable
to rescue the telomere defect observed upon FEN1 depletion despite its ability to localize
to the telomere. Because the ΔC mutant retains a partial ability to interact with PCNA
[23, 24], this result suggests that it is FEN1’s repair function that is critical for its activity
at the telomere.

Materials and Methods
Cell Culture and Synchronization. All cells were grown as reported [29-31]. Briefly,
cells were grown at 37°C in 5% CO2. HeLa and 293T cells were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) containing 10% heat-inactivated fetal calf serum and
1% penicillin/streptomycin. BJ fibroblasts were cultured in DMEM with 15% Medium
199 (Sigma, St. Louis, MO), 15% fetal calf serum and 1% penicillin/streptomycin. HeLa
cells were synchronized using a sequential Thymidine (2mM)-Aphidicolin (1µg/ml)
block (16 hours) with a 10-hour release between them. Centrifugal elutriation was carried
out on 293 cells using a Beckman JE6B elutriation rotor (Beckman). Small fractions of
cells were collected at the indicated time points, stained with propidium iodide, and
subjected to FACS analysis to determine the cell cycle phase before subsequent analyses.
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Virus Production and Infection. Viral production and infections were carried out as
described [32]. Briefly, 293T cells were transfected using TransIT-LT1 (Mirius,
Madison, WI). Virus was harvested 48 hours post transfection, and infections were
carried out in the presence of 10 µg/ml of protamine sulphate for 4-6 hours. Following
infection, target cells were selected with 1 µg/ml puromycin. The pLKO.1shSCRp,
pLKO.1shFENp and pResQ lentiviruses were produced by cotransfection with
pCMVΔR8.2 and pCMV-VSV-G (8:1 ratio). The sequences used for the hairpins were
for

shFEN

5’-GGAGATCGTGCGGCGACTTGA-3’

shFEN3

5’-

TTAAGAGCTACAGCTAGAGAA-3’ and shSCR [33]. The pResQ was constructed by
inserting the U6 promoter into pFIRu (Unpublished data, Dr. Greg Longmore). The U6
promoter was amplified using 5’-TCTAGATGAGGGCCTATTTCCCATGATTCC-3’
and 5’-CTCGAGTACGTAACCGGTGTTTCGTCCTTTCCAC-3’ primers, and inserted
with the XbaI and XhoI endonucleases.

Western Blot Analysis. Cells were washed with PBS and lysed in RIPA buffer (150mM
NaCl, 1% Triton X-100, 0.5% Sodium Deoxycholate, 0.1% SDS, 50mM Tris pH8.0,
aprotonin, leupeptin, pepstatin, and PMSF). Protein concentration was quantified using
the Bio-Rad Protein Assay (500-0006, Bio-Rad, CA) Proteins were separated on an SDSpolyacrylamide gel and transferred to a PVDF membrane.

Antibodies used: rabbit

polyclonal anti-FEN1 (#586, Bethyl Labs, Montgomery, TX), mouse monoclonal antiActin (ABCAM, Cambridge, MA), rabbit polyclonal anti-TRF2 (Santa Cruz Biotech, H300), mouse monoclonal anti-Flag M2 (Sigma St. Louis, MO).
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Co-Immunoprecipitation. 293T nuclear extracts were prepared as described [34].
Nuclear extracts were precleared with 150µl of Protein A beads (Amersham) for 1 hr at
4°C and incubated with 5µg TRF2 antibody (Santa Cruz Biotech, H-300) or IgG (Sigma)
and 40µl of Protein A beads at 4°C, overnight. Bound proteins were eluted and analyzed
by SDS-PAGE and western blot analysis.

Chromatin Immunoprecipitation (ChIP). ChIP was conducted as previously described
with the following modifications [13]. Cells were crosslinked on the plate with 1%
formaldehyde for 60 minutes at room temperature, washed with PBS and lysed in 1%
SDS, 50 mM Tris-HCl, pH 8.0, 10 mM EDTA plus protease inhibitors at a density of
2x107 cells/ml. Lysates were sonicated with a Missonix 3000 sonicator (Missonix, NY)
at a setting of 5 (6 cycles of 30 seconds), producing chromatin fragments ranging from
100 and 500 bases. Equal quantities of protein lysate were diluted and precleared with
40µl of Protein A beads (GE Healthcare, Sweden) for 4 hours at 4°C.
Immunoprecipitations were performed overnight with 8µg of antibodies and 30µl of
Protein A/G-PLUS Sepharose beads (Santa Cruz, sc-2003) that had been pre-blocked
with 5µg of sheared E.coli DNA and 30µg BSA. Antibodies used were: anti-TRF2 (05521,

Upstate,

Charlottesville,

VA),

anti-phospho-H2AX

(JBW301,

Upstate,

Charlottesville, VA), rIgG (Sigma, St. Louis, MO), and anti-Fen1 (#587, Bethyl Labs,
Montgomery, TX). The beads were washed and eluted in 70mM Tris (pH8.0), 1mM
EDTA and 1.5% SDS at 65°C. Crosslinks were reversed by incubation at 65°C for 4-6
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hours. The eluate was treated with 40µg of Proteinase K treatment for an hour at 37°C.
Samples were phenol-chloroform extracted and precipitated overnight at -20°C. The
precipitates were resuspended in 0.4N NaOH and blotted onto a Hybond-XL membrane
(Amersham Biosciences, UK) (70% loaded for telomere signal and 20% loaded for ALU
signal). The telomere probe, TEL (TTAGGG)n and Alu probe (ALU), were produced by
random priming using the Amersham Ready-To-Go beads, -dCTP.

Following

hybridization, membranes were washed and analyzed by a Phosphor Imager (Amersham,
Piscataway, NJ).

Fluorescence in situ Hybridization (FISH). FISH was carried out as described [35]. A
subconfluent population of cells was incubated with 0.1µg/ml of colcemid for 2-6 hours
to allow mitotic cells to accumulate. After hypotonic swelling in 75 mM KCl (10 min,
37°C), cells were fixed in methanol/acetic acid (3:1) and then dropped onto clean glass
slides and aged overnight at 65°C. Slides were rehydrated in PBS, and fixed with 4%
paraformaldehyde (in PBS) for 2 minutes. After washing, the slides were dehydrated
with a cold ethanol series, and hybridized with 0.3µg/ml PNA probes targeted to the
telomere,

Cy3-(CCCTAA)3

and

the

centromere

(FFLU-OO-

CTTCGTTGGAAACGGGA), in 70% formamide, 10mM Tris (pH 7.2) and blocking
agent (Sigma, St. Louis, MO).

DNA was denatured for 3 minutes at 80°C and

hybridization was carried out at 37°C for 2-4 hours in a moist chamber. The slides were
washed in 70% formamide, 10mM Tris (pH 7.2) and 0.1% BSA, and subsequently
washed with TBS-T (0.1M Tris pH 7.2, 0.15M NaCl and 0.08% Tween-20). The slides
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were dehydrated in a cold ethanol series and mounted using VectaShield (Vector Labs,
Burlingame, CA) containing 0.1µg/ml DAPI. Images were taken using a Nikon 90i
Microscope and analyzed on the ISIS FISH imaging software (Metasystems, Altlussheim,
Germany).

Choromosome Orientation-FISH (CO-FISH). CO-FISH was conducted as previously
described [36] with the following modifications. The cells were incubated with BrdU
and BrdC, at the ratio of 3:1 (3µg/ml:1µg/ml) for one cell cycle. Metaphases were
prepared as described above, and processed as described [36]. The metaphases were
probed with Fluorescein-(TTAGGG)3 at 0.06µg/ml and Cy3-(CCCTAA)3 at 0.3µg/ml.
The Flu probe was also boiled for 5 minutes at 95°C in the hybridization buffer, and then
crashed on ice before hybridization.

Statistical Analysis. The Wilcoxon Two-Sample test (two-tailed distribution) was used
for all the FISH analyses. Student’s T-test was used to analyze the ChIP data.
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Figure 2.1. FEN1 depletion leads to telomere dysfunction.
(A) Timeline of experimental procedure given in days. (B) Short hairpins against FEN1
(shFEN) or a scrambled sequence (shSCR) were expressed in BJ fibroblasts. FEN1
(upper panel) and β-Actin (lower panel) protein levels were assessed by Western blot
analysis. (C) Representative ChIP assay of cells expressing shSCR or shFEN. ChIPs were
conducted as described in the supplemental materials. The inputs indicate 0.2%, 0.1%
and 0.04% of the total protein extract. (D) Quantification of six independent ChIP assays.
The graph indicates the relative amount of telomere (Telo) or ALU repeat (ALU) DNA
isolated from cells expressing shSCR (white) or shFEN (black). The error bars represent
standard error of the mean (SEM).
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Figure 2.2. Increased sister telomere loss (STL) upon FEN1 depletion.
(A) Short hairpins against a scrambled sequence (shSCR) or FEN1 (shFEN) were
expressed in BJ fibroblasts expressing SV40 early region, in the absence (BJL) or
presence of telomerase (BJLT). FEN1 (upper panel) and β-Actin (lower panel) protein
levels were assessed by Western blot analysis. (B) Representative metaphases from BJL
and BJLT cells following shRNA expression. FISH analysis was conducted using Cy3[CCCTAA]3 (red) and FLU-labeled centromere probes (green). DNA was stained with
4’,6-diamidino-2-phenylindole (DAPI; blue). Arrowheads indicate missing sister
telomeres. The side panels show higher magnification images of the metaphase
chromosomes. (C) Quantification of chromosomes displaying STLs following shRNA
expression in BJL (black bars) and BJLT (white bars) cells. A minimum of 60
metaphases, from two independent experiments, was analyzed per treatment in a blinded
fashion (* P<0.0001; †, P<0.05). The error bars represent SEM.
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Figure 2.3. FEN1 depletion leads to loss of telomeres replicated by lagging strand
DNA synthesis.
(A) CO-FISH schematic. Newly synthesized strands incorporate BrdU and BrdC. UV and
ExoIII treatment results in degradation of newly synthesized DNA containing BrdU and
BrdC, and the template strands are hybridized with Cy3-[CCCTAA]3 (red, lagging
strand) and FLU-[TTAGGG]3 (green, leading strand) probes. (B) Representative COFISH of metaphases from BJL cells expressing the indicated hairpins. Color schemes are
as described in (A). The arrowheads indicate missing telomeres. (C) Quantification of
(B). A minimum of 60 metaphases from two independent experiments was analyzed per
treatment in a blinded fashion (*P<0.0001). The error bars represent SEM.
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Figure 2.4. The nuclease activity and C-terminal region of FEN1 are essential for its
role at the telomere.
(A) Western blot analysis of endogenous and ectopically expressed FEN1 proteins
following transduction of BJL cells (upper panel). The ectopically expressed FEN1
proteins carry a triple-flag tag (3XF), which produces a larger protein. Abbreviations are
as follows: Ctrl indicates control cells in which GFP was ectopically expressed, 3XF-F
indicates the ectopically expressed wildtype and DA mutant, 3XF-FC indicates the ∆C
mutant, and Endog indicates the endogenous FEN1 protein (*, Non-specific band). βActin (lower panel) is shown as a loading control. (B) Quantification of STLs after COFISH on metaphase chromosomes following depletion of the endogenous protein and
expression of the indicated FEN1 protein, depicted as percentage of chromosomes with
missing leading and lagging strand telomeres. A minimum of 60 metaphases from two
independent experiments was analyzed per treatment in a blinded fashion (†, P<0.0001).
The error bars represent SEM. (C) 293T cells transduced with flag-tagged FEN1 mutants,
DA and ΔC and subjected to immunoprecipitation (IP) with an anti-TRF2 antibody as
described in the supplemental. The presence of TRF2 and the FEN1 mutants were
detected by immunoblot (IB) using anti-TRF2 and anti-Flag antibodies, respectively. The
input lane indicates 10% of total protein used per immunoprecipitation. (D) FEN1
mutants localize to the telomere. Representative ChIP analysis of 293T cells (Ctrl) or
293T cells transduced with wildtype (WT) or a FEN1 mutant (DA and ΔC), subjected to
immunoprecipitation with the M2 flag antibody. Precipitated DNA was probed for the
presence of telomeric sequences as described in the supplemental information. The inputs
indicate 0.2%, 0.1% and 0.04% of the total protein extract.
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Figure 2.S1 FEN1 localizes to the telomere.
(A) Cell Cycle analysis of the HeLa cells used for chromatin immunoprecipitation (ChIP)
assays. FACS analysis of propidium iodide stained synchronized HeLa cells taken at the
indicated times post-release. The percentage of cells in each phase of the cell cycle is
indicated. (B) ChIP with the indicated antibodies on synchronized lysates. Isolated DNA
was probed with a probe against the telomere and Alu DNA. The inputs indicate 0.2%,
0.1% and 0.04% of the total protein extract.
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Figure 2.S2 FEN1 localizes to the telomere.
(A) Cell Cycle analysis of the 293 cells used for ChIP assays. FACS analysis of
propidium iodide stained synchronized 293 cells post elutriation. The percentage of cells
in each phase of the cell cycle is indicated. (B) Representative ChIP assay from the 293
cells separated via centrifugal elutriation using the indicated antibodies. Assays were
conducted using equal amounts of protein extracts. rIgG was used as a negative control.
The input for each of the lysates indicates 0.1% and 0.04% of the total protein extract.
The isolated DNA samples were subjected to southern blot analysis using telomere and
ALU probes. A lighter exposure is provided for the TRF2 telomere panel relative to the
FEN1 panel. (C) Quantification of the relative FEN1 immunoprecipitation in the ChIP
assays (n=2) following normalization for input and efficiency of DNA extraction. The
graph shows relative pulldown compared to the G1 phase. Blue bars indicate the telomere
signal and the red bars indicate the ALU signal.
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Figure 2.S3 FEN1 interacts with TRF2.
Co-immunoprecipitation experiments were conducted with nuclear lysates from HeLa
cells to detect interaction between endogenous proteins. TRF2 was immunoprecipitated
(IP) with anti-TRF2. The presence of FEN1 and TRF2 in the IP was confirmed by
immunoblotting (IB) with antibodies against TRF2 and FEN1 as indicated.
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Figure 2.S4. Schematic representation of the pResQ vector.
A novel retroviral vector capable of: 1) utilizing RNAi to knock down a gene of interest
(shRNA), 2) overexpressing a cDNA, and 3) expressing the puromycin resistance gene,
facilitating isolation of transduced populations.
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Figure 2.S5. The nuclease activity and C-terminal region of FEN1 are essential for
its role at the telomere.
Representative images of metaphases isolated from BJL cells with the indicated
treatments. CO-FISH was conducted on these metaphases and the color schematic is the
same as in Figure 2.3. The white arrowheads indicate missing sister telomeres.
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Table 2.S1. Cytogenetic analysis upon FEN1 depletion in the absence (BJL) and
presence of telomerase (BJLT). Karyotypic analysis was conducted on blinded samples.
Chromosomal
BJL
BJLT
Aberrations
shSCR

shFEN

shSCR

shFEN

Chromosome Gap

1

5

0

0

Minute

0

0

0

0

Chromatid Break

9

24

6

1

Chromatid Gap

0

0

0

0

Chromatid Exchange

10

10

0

0

Tri-Radial

1

1

0

0

Quadra-Radial

0

0

0

0

Dicentric

0

0

0

0

Ring Chromosome

0

0

0

0

Metaphase Number

68

118

41

33
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Abstract

High fidelity telomere replication is critical to telomere stability and genomic stability.
Telomeres present a challenging template for DNA replication and are duplicated by the
coordinated actions of telomere binding proteins and DNA replication and repair
proteins.

Recently, we demonstrated that Flap Endonuclease 1 (FEN1), a nuclease

important for DNA replication and repair, is critical for telomere stability and its
depletion led to a loss of lagging strand-replicated telomeres. Here, we show that FEN1
contributes to telomere stability by ensuring efficient duplication of telomeres. FEN1
depletion does not affect cell cycle progression nor in vitro DNA replication through nontelomeric substrates, suggesting other nucleases compensate for FEN1 loss throughout
the genome during DNA replication. However, FEN1 depletion leads to a decrease in
replication fork re-initiation events following hydroxyurea challenge, indicating that
FEN1 is important for efficient re-initiation of stalled replication forks. Genetic rescue
experiments revealed that a novel gap endonuclease (GEN) activity involved in
processing DNA bubble structures and FEN1’s ability to interact with the RecQ helicases
are vital for FEN1-dependent re-initiation of stalled replication forks.

We further

demonstrate that FEN1’s ability to process Okazaki fragments is not required for efficient
telomere replication. In contrast, FEN1’s GEN activity, which is critical for re-initiation
of stalled forks, prevents replication-dependent loss of lagging strand telomeres. We
propose that FEN1 maintains stable telomeres through the efficient re-initiation of stalled
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replication forks that occur in the G-rich lagging strand telomere, ensuring high fidelity
telomere replication.

Introduction
High fidelity DNA replication is critical for genome stability and continued cellular
proliferation, and is thus ensured by redundant mechanisms. The existence of inherited
syndromes in which DNA replication/repair proteins are mutated or lost and overall DNA
replication is able to continue best illustrate the robustness of these redundant systems
(58). For example, Werner (WRN) helicase function is lost in Werner’s syndrome, yet
these patients replicate their DNA, suggesting that other RecQ helicases compensate for
its function in DNA replication (49, 50). However, this compensation is incomplete and
patients with mutations in WRN manifest progeria syndromes characterized by genomic
instability (48).

Deficiencies in various DNA replication/repair mechanisms become particularly
detrimental in highly repetitive DNA sequences that present unique challenges to the
DNA replication machinery (13, 56).

For example, triplicate repeats can cause

replication fork slippage, resulting in deleterious expansions and deletions (19).
Similarly, telomeric DNA, which consists of repetitive G-rich sequences capable of
forming secondary structures such as G-quadruplexes (G4) can impede the replication
fork (13, 27, 37).

Thus, telomeres are particularly sensitive to the loss of DNA
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replication/repair proteins such as WRN. Indeed, cells from WRN patients display overt
telomere dysfunction while displaying only minor defects in overall genomic replication
(6, 7, 48), suggesting that other proteins partially compensate for WRN throughout the
genome but are unable to fully compensate for WRN function at the telomere.

Given the difficulties encountered during telomere replication, robust mechanisms have
evolved to ensure high fidelity replication and repair of the telomere. These mechanisms
appear to be coordinated by the Shelterin complex, a six-protein complex of telomere
binding proteins (10, 13, 56). Indeed, TRF2, an essential component of the Shelterin
complex, interacts with and modulates the activities of numerous DNA replication and
repair proteins (10). For example, TRF2 binds WRN and BLM helicases and stimulates
their activity in vitro, suggesting that it recruits them to replicate/repair telomeric DNA
(36). In Schizosaccharomyces pombe (S. pombe), the TRF1/2 homolog, Taz1 is essential
for DNA replication through the telomeres (30). Upon Taz1 deletion, replication forks
stall and telomeres are rapidly lost (30). TRF1 plays a similar role in mammalian cells
(43).

Following deletion of TRF1, stalled replication forks accumulate within the

telomeric repeats and an ATR-dependent DNA damage response (DDR) is detected,
indicating a replication defect (43). Together, these data underscore the importance of
the coordinated action between Shelterin components and the DNA replication and repair
machinery to ensure efficient telomere replication.
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We recently demonstrated that FEN1, a structure-specific metallonuclease that
participates in DNA replication and repair, is vital for maintaining telomere stability (39).
FEN1 directly participates in processing of Okazaki fragments during lagging strand
replication (23). FEN1 also participates in several DNA repair pathways including base
excision repair, homologous recombination, and re-initiation of stalled replication forks
(26, 47). In addition, FEN1 directly interacts with TRF2 and localizes to mammalian
telomeres during S-phase (32, 39, 57). Recently, we demonstrated that FEN1 depletion in
telomerase-deficient cells results in a DNA damage response (DDR) at telomeres and
telomere dysfunction characterized by loss of sister telomeres (STL) replicated by the
lagging strand machinery (39, 40).

Furthermore, genetic rescue experiments

demonstrated that the nuclease activity and the C-terminus, WRN-interacting domain
were important for FEN1 function at the telomere (39).

Here we demonstrate that FEN1 promotes efficient re-initiation of stalled replication
forks. The C-terminal domain of FEN1 and its novel gap endonuclease activity (GEN)
are critical for its ability to re-initiate stalled replication forks. However, FEN1 depletion
does not affect progression through S-phase nor SV40 Large-T-dependent in vitro DNA
replication.

Finally, we demonstrate that the PCNA-interacting domain of FEN1 is

dispensable for its telomere function, and that the GEN activity of FEN1 is critical for its
ability to prevent STLs upon FEN1 depletion. We propose that FEN1 maintains stable
telomeres through the efficient re-initation of stalled replication forks that occur in the Grich telomere, ensuring high fidelity telomere replication.

70

Materials and Methods
Cell Culture. All cells were grown as reported (39, 40, 51, 53). Briefly, cells were
grown at 37°C in 5% CO2. HeLa and 293T cells were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) containing 10% heat-inactivated fetal calf serum and 1%
penicillin/streptomycin. BJ fibroblasts were cultured in DMEM with 15% Medium 199
(Sigma,

St.

Louis,

MO),

15%

heat-inactivated

fetal

calf

serum

and

1%

penicillin/streptomycin.

Virus Production and Infection. Lentiviral production and cell infections were carried
out as described (39, 40, 52). Briefly, 293T cells were transfected with TransIT-LT1
(Mirius, Madison, WI). Virus was harvested 48 hours post transfection, and infections
were carried out overnight in the presence of 10 µg/ml of protamine sulfate. Following
infection, transduced cells were selected with 1 µg/ml puromycin.

For adenovirus

production, FEN1 cDNAs were cloned into the pShuttle vector (Stratagene, La Jolla, CA)
at the EcoRV site. The hWT, DA and ΔC cDNAs were previously described (39); the ΔP
cDNA was previously described (45); the ΔPΔC cDNA was constructed using a forward
primer

complementary

to

the

flag

epitope

5’-

GGTACCATGGACTACAAAGACCATGACGG-3’ and the following reverse primer,
5’-CTCGAGTTATTAGGTGCTGCCTTGGCGGCTCTTAC-3’, and cloned into the
pShuttle plasmid; the mWT and mED cDNAs were previously described (62). Following
subcloning, the FEN1 cDNAs were recombined into the pAdEasy-1 plasmid (Stratagene,
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La Jolla, CA) and the resultant DNA was transfected into HEK293 cells to produce
infectious adenovirus. The adenovirus production and concentration was carried out
according to manufacturer’s protocol using the AdEasy XL Adenoviral Vector System
(Stratagene, La Jolla, CA). The titer of the concentrated adenovirus was determined
using AdEasy Viral Titer kit (Strategene, La Jolla, CA) according to the manufacturer’s
protocol.

Western Blot Analysis. All western blots were conducted as described (39). Antibodies
used: rabbit polyclonal anti-FEN1 (#586, Bethyl Labs, Montgomery, TX), mouse
monoclonal anti-Actin (ABCAM, Cambridge, MA), rabbit polyclonal anti-TRF2 (H-300;
Santa Cruz Biotech, Santa Cruz, CA), mouse monoclonal anti-Flag M2 (Sigma St. Louis,
MO), rabbit polyclonal anti-Cyclophilin A (Cell Signaling Technology, Danvers, MA).

S-phase progression assay. HeLa cells were cultured for 1 hour in the presence of
50µM 5-bromo-2-deoxyuridine (BrdU).

The cells were then washed in phosphate

buffered saline (PBS), replaced in culture medium and harvested at the indicated times.
The harvested cells were washed with PBS and then fixed in 4% paraformaldehyde and
0.1% TritonX-100 in PBS for 20 minutes at room temperature. Cells were further
permeabilized with 0.1% TritonX-100 for 10 minutes on ice and fixed again for 5
minutes as previously described. The DNA was denatured with 30µg of DNaseI (Sigma,
St. Louis, MO) at 37°C for an hour. The BrdU was detected with a FITC-conjugated
anti-BrdU antibody (A21303, Invitrogen, Carlsbad, CA) and the DNA content of the cells
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was determined by 7-amino-actinomysin D (7-AAD; BD Biosciences, San Jose, CA)
staining. The stained cells were analyzed on a FACSCalibur machine (BD Biosciences,
San Jose, CA).

SV-40 Large-T Antigen dependent in vitro DNA replication assay. The crude cell
extracts for this assay were prepared using HeLa cells as described in (4). Briefly, HeLa
cells were harvested, washed in cold isotonic buffer [20mM HEPES, pH 7.8, 1.5mM
MgCl2,

5mM

KCl,

250mM

sucrose,

1mM

dithiothreitol

(DTT),

0.1mM

phenylmethylsulfonyl fluoride (PMSF)], and then with cold hypotonic buffer (isotonic
buffer without sucrose). The cells were then swollen on ice for 15 minutes in hypotonic
buffer and lysed with 10 strokes of the Dounce homogenizer (pestle B). The cell lysate
suspension was kept on ice for another 60 minutes. Following this incubation, the lysate
was centrifuged at 1700g at 4°C for 10 minutes to remove the nuclei and then centrifuged
again at 12,000g for 10 minutes at 4°C to clarify the lysate. The resulting lysate was
flash frozen in liquid nitrogen and stored at -80°C. Linear plasmid DNA (pSVO.11-2K;
(34)) used in the replication reactions was prepared by equilibrium centrifugation in
cesium chloride-ethidium bromide gradients and then digested with BbsI. The in vitro
replication reactions were carried out according to the protocol in (4). Briefly, each 25µL
reaction contained 30mM HEPES, pH 7.5, 7mM MgCl2, 4mM rATP, 50µM each of
rCTP, rUTP, rGTP, 100µM each of dATP, dGTP, dTTP, dCTP, 0.5mM DTT, 40mM
creatine phosphate, 0.625 units creatine phosphokinase, 20µM [α-32P]dCTP (1µCi), 50ng
linearized plasmid DNA, 1µg Large-T antigen (Chimerx, Madison, WI) and 100µg
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cytoplasmic extract. The reaction was incubated for 10 minutes on ice and then at 37°C
for the indicated time. To stop the reaction, an equal volume of stop solution (2% SDS,
50mM EDTA, 1mg/ml Proteinase K) was added and the reaction was incubated for an
additional

30

minutes

at

37°C.

The

reactions

were

subject

to

a

phenol/chloroform/isoamyl alcohol extraction and then the DNA was precipitated. The
precipitated DNA was separated on an agarose electrophoresis gel to determine
replication products that were quantified using a Phosphor Imager (Amersham,
Piscataway, NJ).

Replication Re-initiation assay. The protocol was adapted from (17, 42). Briefly, cells
were cultured with 1.5mM hydroxyurea (HU) for 16 hours. The cells were then released
from HU inhibition into medium containing 150µM BrdU for 10 minutes. The cells were
fixed immediately, permeabilized with 0.5% TritonX-100, and treated with 10units of
DNaseI at 37°C for 1 hour to denature the DNA. The antibodies used for staining were
mouse anti-BrdU (BD Biosciences, San Jose, CA); rabbit anti-FLAG (Sigma, St. Louis,
MO); Alexa Fluor 488 goat anti-mouse and Alexa Fluor 546 goat anti-rabbit (Invitrogen,
Carlsbad, CA).

Co-Immunoprecipitation (Co-IP). Co-IP was conducted as described (39). Briefly,
293T cells were transfected with the indicated cDNA constructs and then nuclear extracts
were prepared as described (12). Nuclear extracts were precleared with 150µl of Protein
A beads (GE Healthcare, Piscataway, NJ) for 1 hr at 4°C and incubated with 5µg TRF2
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antibody (H-300; Santa Cruz Biotech, Santa Cruz, CA) or IgG (Sigma, St. Louis, MO)
and 40µl of Protein A beads at 4°C, overnight. Bound proteins were eluted and analyzed
by SDS-PAGE and western blot analysis.

Chromatin Immunoprecipitation (ChIP). ChIP was conducted as described (39).

Metaphase preparation and Chromosome Orientation-FISH (CO-FISH). Metaphase
preparation and CO-FISH was conducted as described (39).

Statistical Analysis. The Student’s T-test (two-tailed distribution with equal variance)
was used for all the BrdU foci and CO-FISH analyses.

Results
FEN1 depletion leads to inefficient replication fork restart
FEN1 is a structure-specific endonuclease that plays an important role in DNA
metabolism. FEN1 participates in Okazaki fragment processing during lagging strand
DNA replication and is important for several DNA repair processes (26, 47). Indeed,
FEN1 localizes to stalled replication forks where it interacts with the RecQ helicase,
Werner (WRN), and is postulated to participate in DNA replication fork re-initiation (44,
62).

The telomeric DNA sequence presents a challenging template for the DNA
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replication machinery. As such, telomeres resemble fragile sites that are revealed upon
aphidicolin treatment (43), providing evidence that telomeric replication is challenging.
Furthermore, replication fork pausing and stalling have been observed within telomeric
repeats both in vitro and in vivo (18, 28, 34, 57). This suggests that high fidelity telomere
replication requires the actions of a replication fork re-initiation complex.

Recently, we demonstrated that in human cells FEN1 depletion results in telomere
dysfunction while having little impact on total genome stability (39). These results were
intriguing as they suggested that other proteins compensate for FEN1 depletion during
genomic replication and/or repair but these same proteins are ineffective within telomeric
sequences. Interestingly, the FEN1ΔC mutant that does not interact with the Werner
protein is unable to rescue telomere dysfunction upon depletion of endogenous FEN1,
although it is able to bind the telomere (39, 45). It is therefore interesting to speculate
that FEN1 is required for the re-initiation of stalled replication forks at telomeres. Given
the data implicating FEN1 in replication fork re-initiation we first addressed how FEN1
depletion impacted DNA replication fork re-initiation following forced fork stalling
induced by hydroxyurea treatment.

Hydroxyurea treatment causes nucleotide depletion, resulting in DNA replication fork
stalling and S-phase arrest. Upon removal of hydroxyurea, nucleotide pools recover and
stalled DNA replication forks re-initiate, allowing S-phase to proceed. To investigate
whether FEN1 contributes to DNA replication fork re-initiation, we induced stalled DNA
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replication forks in HeLa cells by treating them with hydroxyurea for 16 hours and then
releasing them in the presence of BrdU for ten minutes.

Because BrdU is only

incorporated where the DNA replication forks re-initiate, the efficiency of repair can be
determined by quantitating BrdU foci (Figure 3.1A) (17). If FEN1 participates in the
repair and restart of stalled DNA replication forks, its depletion would cause fewer reinitiation events and thus fewer BrdU foci would be observed.

HeLa cells were transduced with a lentiviral construct encoding a short hairpin RNA
(shRNA) targeting the FEN1 3’UTR (shFEN3) or a control hairpin (shSCR) (39).
Expression of shFEN3 led to a significant reduction in FEN1 protein compared to cells
expressing shSCR (Figure 3.1B). Control cells and FEN1-depleted cells were cultured
for 16 hours in the presence of hydroxyurea (HU) and then released from HU inhibition
in the presence of BrdU for ten minutes (Figure 3.1A). BrdU foci were observed
through immunostaining. As expected, we observed a striking decrease in the number of
BrdU foci upon FEN1 depletion, indicating that FEN1 is important for the re-initiation of
stalled DNA replication forks in vivo (Figure 3.1C and 3.1D). In cells expressing the
control hairpin, there were an average of 15 BrdU foci per cell. In contrast, FEN1
depletion led to an average of 6.5 BrdU foci per cell, a greater than 50% decrease
(P<0.0001; Figure 3.1D). Importantly, even in the absence of FEN1, cells were able to
re-initiate stalled DNA replication forks, albeit less efficiently. Together these results
demonstrate that FEN1 is important for efficient repair/restart of stalled DNA replication
forks.
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To date, the biochemical properties of FEN1 critical to the restart of stalled DNA
replication forks have not been determined. Therefore, we next carried out the reinitiation assay described above in cells depleted of endogenous FEN1 and expressing
various FEN1 mutants as outlined in Figure 3.2B. The different FEN1 proteins used in
this study included 1) human wildtype (hWT), which is competent for both replication
and repair functions; 2) D181A (DA), which lacks nuclease activity (46) and thus
represents a loss-of-function allele; 3) delta C (ΔC; 20 amino acid deletion on the Cterminus), which retains near wildtype ability to process flap structures with the
replication clamp, PCNA, but is unable to bind the BLM and WRN helicases and
participate in FEN1’s DNA repair functions (45, 54); 4) delta P (ΔP; 9 amino acid
deletion in the gene), which retains the ability to interact with the RecQ helicases, BLM
and WRN, but is unable to interact with the replication clamp, PCNA (45), thus rendering
it replication incompetent yet repair competent; and 5) deltaP-deltaC (ΔPΔC; 44 amino
acid deletion on the C-terminus), which deletes FEN1’s nuclear localization signal and
abrogates its ability to interact with PCNA, BLM and WRN (45), thus creating a second
loss-of-function allele that retains the nuclease domain. In addition, we also expressed a
murine E160D (mED) mutant, which retains near wild-type levels of flap endonuclease
(FEN) activity and the ability to participate in DNA replication, but is devoid of the novel
gap endonuclease (GEN) activity, involved in processing DNA bubble structures and
hypothesized to function in DNA repair including the re-initiation of stalled replication
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forks (25, 62). Finally, we also expressed a murine wildtype (mWT) protein as a control
for the mED mutant.

To facilitate our analysis, we utilized an shRNA that targeted the FEN1 3’ untranslated
region (shFEN3), which allowed depletion of the endogenous protein while having no
effect on expression of the various FEN1 cDNAs (39, 40). Following depletion of FEN1,
cells were subsequently infected with an adenovirus expressing wildtype or a mutant
FEN1 protein. Transduced cells were allowed to grow for 4 days and then treated with
HU for 16 hours followed by a 10 minute BrdU pulse to label re-initiated DNA
replication forks (Figure 3.2A). To facilitate identification of successfully transduced
cells, each of the FEN1 constructs was tagged with a Flag epitope. Therefore, following
the BrdU pulse, cells were fixed and stained with anti-BrdU and anti-Flag antibodies and
BrdU foci were quantitated in Flag-positive cells. As expected, expression of hWT
FEN1 recovered the number of BrdU foci in FEN1-depleted cells to that observed in
control cells. Indeed, expression of wildtype FEN1 led to an average of 18 BrdU foci per
nucleus compared to 6.5 foci in FEN1 depleted cells, demonstrating that the phenotype
observed was specific to FEN1 loss (Figure 3.2C & 3.2D). In contrast, expression of the
nuclease deficient FEN1 mutant, DA, did not rescue FEN1 depletion and resulted in an
average of 5.5 foci per nucleus, indicating that the nuclease activity of FEN1 is critical
for its function in the repair of stalled DNA replication forks (Figure 3.2C & 3.2D).
Similarly, expression of FEN1ΔC also failed to rescue the decreased number of BrdU
foci observed in FEN1 depleted cells. Because this mutant is able to interact with PCNA

79

and is competent for Okazaki fragment processing, this result suggests that the interaction
between FEN1 and the RecQ helicases, BLM and WRN is important for FEN1’s role in
the repair of stalled DNA replication forks (Figure 3.2C & 3.2D). In agreement, we
found that expression of the ΔP mutant resulted in an average of 15.6 BrdU foci (Figure
3.2C & 3.2D), demonstrating that FEN1’s interaction with PCNA is not critical for its
role in the repair of stalled DNA replication forks. As expected, expression of the ΔPΔC
mutant, a functionally null allele, was unable to rescue the reduction in BrdU foci
observed upon FEN1 depletion (Figure 3.2C & 3.2D).

Analysis of our FEN1 mutants indicated that FEN1’s DNA repair function and not its
ability to participate in Okazaki fragment processing is critical for the restart of stalled
DNA replication forks. Recently, a novel activity referred to as GAP endonuclease
(GEN) was ascribed to FEN1 (62). The existence of this activity was intriguing because
it has the ability to cleave DNA bubble structures, which resemble stalled replication
forks. Furthermore, WRN stimulates FEN1’s GEN activity, (25), suggesting that this
activity is functionally important at stalled replication forks.

To establish whether the

GEN function was important for the restart of stalled replication forks, we next tested the
impact of expression of a GEN-deficient FEN1 mutant (mED). Expression of the mED
mutant failed to rescue the phenotype observed in FEN1 depleted cells, which displayed
an average of 5.1 BrdU foci per nucleus (Figure 3.2C & 3.2D). As expected, the
wildtype protein, mWT completely recovered the number of BrdU foci observed upon
FEN1 depletion with an average of 13.7 foci per nucleus (Figure 3.2C & 3.2D). These
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data indicate that the GEN activity of FEN1 plays an important role in the repair/restart
of stalled DNA replication forks. Taken together, these data support the hypothesis that
FEN1 is important for the re-initiation of stalled replication forks. Moreover, FEN1’s
gap endonuclease activity and ability to interact with the RecQ helicases, BLM and
WRN, are critical for this function.

FEN1 depletion does not impact S phase progression
Previously we showed that FEN1 depletion in telomerase-positive cells led to mild
telomere dysfunction in the absence of cytogenic abnormalities (39). Furthermore, we
showed that FEN1’s ability to interact with the WRN protein was important in its
function at telomeres and therefore ascribed the telomere dysfunction to FEN1’s DNA
repair activities (39). Above, we demonstrate that FEN1 directly contributes to the restart
of stalled DNA replication forks and that this does not depend on FEN1’s activity in
Okazaki fragment processing but rather its DNA repair activities. Because the BrdU foci
assay described above recognizes replication fork re-initiation across the genome, we
wished to further examine how FEN1 depletion impacted genomic replication.
Therefore, to explore the effect of FEN1 depletion on DNA replication, we utilized
shRNA technology to deplete FEN1 and determine its impact on S-phase progression.
Because telomere dysfunction might impact S-phase progression and this defect is
rescued in telomerase positive cells (40), telomerase-positive HeLa cells were transduced
with a lentiviral construct encoding shFEN3 or a control hairpin (shSCR). Expression of
shFEN3 led to a significant reduction in FEN1 protein compared to cells expressing
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shSCR (Figure 3.1B). To follow cells through the cell cycle, cells were pulsed with
BrdU for one hour to label the S-phase population and then cells were followed as they
continued through the cell cycle (Figure 3.3A). As expected from our previous work, in
the absence of telomere dysfunction, we did not observe a significant difference in Sphase progression when cells were transduced with shFEN or shSCR (Figure 3.3A &
3.3B). As shown in Figure 3.3, in both cell lines approximately 35% of the cells were in
S-phase following the one hour BrdU pulse. Both the control and FEN1-depleted cells
exited S-phase and progressed throughout the cell cycle with similar kinetics (Figure
3.3B). This data suggests that FEN1 is not essential for DNA replication in vivo and its
depletion does not significantly impact cell cycle progression.

FEN1 depletion does not impact DNA replication kinetics in vitro
Our initial studies indicated that FEN1 depletion has no detectable impact on S phase
progression. Because minor effects on DNA replication might be missed by this assay,
we next examined the impact of FEN1 depletion on DNA replication kinetics through
non-telomeric DNA sequences.

To measure replication kinetics in the presence or

absence of FEN1, we conducted an SV-40 Large-T antigen-dependent in vitro DNA
replication assay (4) using cell lysates isolated from control or FEN1-depleted HeLa cells
(Figure 3.3C). The DNA replication reaction was reconstituted with lysates from control
or FEN1 depleted cells and carried out for 0, 15, 30, 60 and 120 minutes. As shown in
Figure 3.3D and 3.3E, there was no difference in DNA replication efficiency when
lysates from control versus FEN1-depleted cells were used (Figure 3.3E), indicating that
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DNA replication proceeded in FEN1-depleted lysates with the same efficiency as lysates
obtained from control cells. These results are in agreement with our S-phase progression
data and suggest that another nuclease compensates for FEN1 function during DNA
replication in non-telomeric sequences.

FEN1 interacts with the Shelterin component, TRF2
Our previous work (39) and the data in this paper support the hypothesis that FEN1
activity at the telomere is critical for high fidelity replication. The data further suggest
that other nucleases are capable of compensating for FEN1 across the genome but fail to
do so at the telomere. Given these results, we next wished to characterize the impact of
the FEN1 mutants described above at the telomere. Because recent work demonstrated
that FEN1 localizes to the mammalian telomere and interacts with the Shelterin
component, TRF2 (32, 39, 57), we first examined the ability of the FEN1 mutants to
interact with TRF2 and localize to the telomere.

To assess the interaction between TRF2 and the various FEN1 mutants, 293T cells were
transfected with constructs expressing Flag-tagged wildtype or mutant FEN1 proteins.
Nuclear

lysates

were

obtained

from

the

transfected

cells

and

subject

to

immunoprecipitation with an anti-TRF2 antibody followed by western blot analysis. To
restrict our analysis to the ectopically expressed FEN1 proteins, western blot analysis was
carried out using an anti-Flag antibody.

As shown in Figure 3.4A, TRF2

immunoprecipitated the ΔP FEN1 mutant, indicating that deletion of the PCNA-
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interacting domain did not impair FEN1’s ability to interact with TRF2. Given that our
previous work indicated that the ΔC FEN1 mutant was unable to interact with TRF2 (39),
it was not surprising to find that the ΔPΔC FEN1 mutant also failed to interact with TRF2
(Figure 3.4A). Analysis of the mWT FEN1 protein revealed that it, as well as the mED
mutant, interacted with TRF2 (Figure 3.4A).

We next carried out chromatin immunoprecipitation (ChIP) experiments to determine
whether the various FEN1 mutants retained the ability to localize to the telomere. As
expected the hWT and ΔP mutant FEN1 localized to the telomere (Figure 3.4B and
3.4C). In contrast, the ΔPΔC FEN1 mutant was unable to precipitate telomeric DNA
(Figure 3.4B and 3.4C). As above, the latter result was expected because the ΔPΔC
mutant lacks the nuclear localization domain and is unable to localize to the nucleus
(Figure 3.2B and 3.2C). Finally, both the mWT and mED proteins localized to the
telomere. Together, these data indicate that the ability of FEN1 to interact with TRF2
and telomeric DNA correlate, suggesting that TRF2 might recruit FEN1 to the telomere
for specialized processing and/or repair of telomeric DNA.

FEN promotes telomere stability by facilitating DNA replication fork re-initiation
The telomere consists of G-rich repetitive DNA that has the propensity to form Gquadruplex structures that can impede the movement of the DNA replication fork (13, 27,
30, 34, 57).

Indeed, it has been hypothesized that stalled DNA replication forks

frequently occur in the telomere (13, 57). Failure to resolve a stalled DNA replication
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fork within the telomere would lead to fork collapse, formation of a double strand DNA
break and telomere loss (3). In support of this, recent studies have suggested that
collapsed replication forks exist at telomeres leading to the formation of very short
telomeres (7, 18, 59). We recently demonstrated that FEN1 depletion results in telomere
dysfunction characterized by STLs (39), indicating that FEN1 functions in telomere
maintenance, either through DNA replication or through DNA repair. Given these results
and our observations indicating that FEN1 contributes to the efficient re-initiation of
stalled DNA replication forks (Figure 3.1), we next wished to determine whether it was
FEN1’s role in Okazaki fragment processing or the restart of stalled DNA replication
forks that contributed to telomere stability. Because telomerase expression compensates
for FEN1 loss at the telomere thus masking the STL phenotype (39, 40), we utilized
primary BJ fibroblasts, which express insufficient telomerase to maintain telomere
lengths (29) for these studies.

Primary BJ fibroblasts were transduced with an shRNA construct targeting the 3’UTR
(shFEN3) to deplete the cells of endogenous FEN1 (Figure 3.5B and 3.5C). Following
depletion of FEN1, cells were infected with an adenovirus expressing wildtype or mutant
FEN1 (greater than 85% of the cells were infected; data not shown). Because FEN1
depletion leads to lagging strand specific sister telomere loss (STL), we analyzed the
strand specific loss of telomeres in cells expressing the different FEN1 mutants (39). To
carry out this analysis, we utilized a technique referred to as chromosome orientation
fluorescent in situ hybridization (CO-FISH), which takes advantage of the fact that the G-
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and C-rich strands of the telomere are replicated by lagging and leading strand DNA
synthesis, respectively (Figure 3.5A). In agreement with our previous results (39), the
CO-FISH analysis demonstrated that FEN1 depletion led to a specific loss of 9.8% of
lagging strand replicated telomeres (up from 3.1% in the control shSCR cells; P<0.0001)
while having no impact on telomeres replicated by the leading strand machinery (Figure
3.5). Expression of wild-type FEN1 rescued the lagging strand STL phenotype (3.2%
lagging strand STLs were observed, similar to that observed in shSCR control cells),
indicating that the observed phenotype was specific to FEN1 depletion (Figure 3.5).
Similarly, expression of the ΔP FEN1 mutant resulted in 3.6% lagging strand STLs
(P<0.0001 compared to shFEN3), indicating that FEN1’s interaction with PCNA was not
important for its function at the telomere (Figure 3.5). In contrast, expression of the
ΔPΔC protein led to 8% lagging strand STLs, indicating that it failed to rescue telomere
dysfunction upon FEN1 depletion (Figure 3.5). Intriguingly, in contrast to the mWT
protein, which was able to rescue the lagging strand STL defect upon FEN1 depletion,
the mED mutant failed to rescue the depletion of FEN1 at the telomere (Figure 3.5).
Indeed, expression of mWT significantly decreased the number of lagging strand STLs
observed upon FEN1 depletion to 2.8%, while expression of the mED mutant resulted in
lagging strand STLs (9.7%, P<0.0001) similar to that observed in ΔPΔC expressing cells.
Because the mED mutant retains the ability to interact with TRF2 (Figure 3.4A) and
localize to the telomere (Figure 3.4B and 3.4C) this result indicates that the gap
endonuclease activity is critical for FEN1’s role at the mammalian telomere. Taken
together, these data demonstrate that FEN1’s interaction with PCNA is dispensable for its
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role at the telomere and that FEN1’s gap endonuclease function is critical for telomere
stability.

Discussion
Telomeres perform a critical cellular function by distinguishing the chromosome end
from a bona fide double stranded DNA break. As such, numerous mechanisms have
evolved to protect the telomere including components of the Shelterin complex that bind
to the unique six base pair repeat sequence. The nature of the telomeric DNA sequence
offers a number of challenges to the cell during DNA replication. G-rich, telomeric
repetitive sequences have a high propensity to form secondary structures such as Gquadruplexes (G4) that impede the progressing replication fork, leading to the formation
of stalled forks (13, 27, 37). Indeed, several reports have indicated pausing and/or
stalling of replication forks moving through telomeres (14, 18, 28, 57). Additionally,
telomere replication is primarily initiated by the most distal origin of replication from the
centromere and continues unidirectionally towards the end of the telomere (43). Given
that telomeres are particularly susceptible to replication fork stalling (14, 18, 28, 57) and
if the stalled fork cannot be resolved, it will lead to the formation of a double strand break
(3) and telomere deletion will result. In support of this, telomeres have been recently
identified as fragile sites that are highly sensitive to replication stress (43). Therefore
successful telomere replication requires specialized machinery such as the coordinated
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action of telomere binding proteins and their recruitment and/or modification of
traditional DNA replication and repair factors (13, 56).

Recent reports demonstrate that Taz1 in S. pombe and TRF1 in mice are required for
efficient telomere replication (30, 43).

Telomere-binding proteins have evolved

mechanisms to facilitate replication fork progression through the telomere possibly by the
recruitment of proteins involved in DNA replication and repair (43). TRF1 and TRF2
interact with and stimulate the RecQ helicases, BLM and WRN (24, 35, 43), suggesting
that they recruit these proteins to enhance DNA repair at the telomeres. FEN1 also
interacts with TRF2 (32, 39). This raises the possibility that TRF2 engages the RecQ
helicase-FEN1 complex coordinately at the telomere.

Interestingly, a recent study

demonstrated that TRF2 increases branch migration of Holliday Junction (HJ)
intermediates suggesting that this promotes the formation of chickenfoot structures in the
context of a stalled replication fork at telomeres (38). TRF1 and TRF2 may then recruit
the WRN-FEN1 complex to resolve this structure and enable efficient restart of the
stalled replication fork (44).

FEN1 localizes to stalled replication forks with the WRN helicase and together they
process branch migrating structures that resemble regressed replication forks (44). In
addition, WRN was shown to be essential for the re-initiation of stalled replication forks,
in vivo (11, 49). The present study demonstrates for the first time that FEN1 is important
for the re-initiation of stalled replication forks in vivo (Figure 3.1). Together with
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previous work (33), this indicates that FEN1’s role in S-phase is two-fold 1) in DNA
replication through processing of Okazaki fragments and 2) in DNA repair through the
re-initiation of stalled replication forks. FEN1 localizes to mammalian telomeres during
S-phase (39, 57) so it could be involved in one or both of the functions outlined above.
However, given that the PCNA-interacting domain of FEN1 is dispensable for telomere
stability, our data indicate that FEN1’s role in Okazaki fragment processing is nonessential for telomere stability. This result indicates that other nucleases such as Dna2 or
Exo1, which can also process Okazaki fragments (1, 2, 15, 16, 31), compensate for FEN1
loss during lagging strand DNA replication. However, these same nucleases fall short
when replication forks stall within the telomeric sequences. Indeed, we find that in the
absence of FEN1’s ability to re-initiate stalled replication forks, sister telomeres are still
lost despite the presence of Dna2 and Exo1. Interestingly, other proteins involved in the
re-initiation of stalled replication forks, PARP1 and PARP2, have also been implicated in
telomere maintenance (5, 8, 60), further indicating the importance of the re-initiation
process for the efficient replication of telomeres.

A novel activity of FEN1, the gap endonuclease (GEN) activity, which is essential for
FEN1’s ability to re-initiate stalled replication forks (Figure 3.2) is also essential for
FEN1 function at telomeres (Figure 3.5).

In support of our data, a recent report

demonstrates telomere dysfunction in mouse embryonic fibroblasts (MEFs) that have a
knock-in of the E160D (mED) mutation (41). Strikingly, mice with the mED knock-in
spontaneously develop lung cancer (61) and lymphomas (22). Importantly, mED knock-
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in mice displayed a modest increase in mutation rates and limited genomic instability
(22), suggesting that telomere dysfunction induces genomic instability and drives this
transformation process. Additionally, several reports have indicated a role for FEN1 as
an important tumor suppressor gene (20-22, 33), suggesting that its role in preserving
telomere stability may affect tumorigenesis.

Intriguingly, the C-terminal region of FEN1, essential for its function at the telomere, is
also essential for its interaction with another RecQ helicase, BLM (45). Similar to WRN,
BLM is also able to unwind G4 DNA, is critical for the re-initiation of stalled replication
forks and has recently been suggested to be important for the efficient replication of
telomeres (9, 42, 43, 55). This suggests that there is complicated interplay between the
RecQ helicases, WRN and BLM, and FEN1 at mammalian telomeres, although the effect
of BLM depletion on normal human telomeres has not been well characterized.
Together, these data indicate that FEN1, together with the RecQ helicases (WRN and
BLM), plays an important role in the re-initation of stalled replication forks at
mammalian telomeres.

Here we demonstrate that FEN1 is important for efficient re-initiation of stalled
replication forks in vivo. This repair function of FEN1 is dependent on its C-terminal
domain and its novel GEN activity. However, despite the importance of FEN1 in reinitiation of stalled replication forks, FEN1 depletion in telomerase-positive cells did not
affect S phase progression or SV40 Large-T antigen-dependent in vitro DNA replication,
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suggesting that other nucleases compensate for FEN1 activity throughout the genome.
However, these same proteins fail to compensate for FEN1 at the telomere. Indeed,
FEN1 depletion led to an increase in lagging strand STLs. As with the re-initiation of
stalled replication forks, both FEN1’s C-terminus and GEN activity were essential for its
function at telomeres while its ability to interact with PCNA was dispensable.
Collectively, these data demonstrate that FEN1 is necessary for efficient replication of
telomeres.
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Figure 3.1. FEN1 depletion decreases re-initiation of stalled replication forks.
(A) Schematic of the stalled replication fork re-initiation assay. HU – Hydroxyurea. (B)
Western blot showing FEN1 depletion. Short hairpins against FEN1 (shFEN3) or a
scrambled sequence (shSCR) were expressed in HeLa cells. FEN1 (upper panel) and βActin (lower panel) protein levels were assessed by Western blot analysis. (C)
Representative images showing FEN1 depletion decreases BrdU incorporation in HU
treated cells. Immunofluorescence was conducted using anti-BrdU (green) and DAPI
(blue). (D) Quantification of the number of BrdU foci per cell in HeLa cells with the
indicated shRNA. BrdU foci in minimum of a 100 cells were counted for each condition
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and the experiment was conducted twice (a representative experiment is presented). The
error bars show standard error of the mean (SEM) (*P<0.0001).
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Figure 3.2. The gap endonuclease activity and C-terminal of FEN1 are essential to
re-initiate stalled replication forks.
94

(A) Timeline of experimental procedure given in days. (B) Schematic showing the
different mutants of FEN1 used in the subsequent experiments with the different domains
of FEN1 and the deletions/mutations. Inferences on whether the different mutants of
FEN1 are replication competent or repair competent are shown on the right of the
schematic with their associated references. These inferences were made based on
nuclease activity and ability to interact with the WRN and PCNA proteins. (C)
Representative images showing BrdU incorporation, after exposure to HU, in FEN1
depleted cells with the indicated adenovirus treatment. Immunofluorescence was
conducted using anti-BrdU (green), anti-FLAG (red) and DAPI (blue).
(D)
Quantification of the number of BrdU foci per cell in FEN1-depleted HeLa cells with the
indicated adenovirus. Only cells exogenously expressing FLAG-tagged FEN1 (marked
by the red cells in C) were quantified. A minimum of a 75 cells was counted for each
condition and the experiment was conducted twice (a representative experiment is
∆
presented). The error bars show SEM (*P<0.0001 compared to shSCR; P<0.0001
#

compared to hWT; P<0.0001 compared to mWT).
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Figure 3.3. FEN1 depletion does not affect S-phase progression and in vitro DNA
replication.
(A) Progression of cells through the different phases of the cell cycle. HeLa cells
expressing shSCR or shFEN3 were labeled with BrdU for one hour and analyzed at the
indicated times using the anti-BrdU antibody (FITC-conjugated) and 7-aminoactinomysin D (7-AAD) to mark DNA content. (B) Graph showing the quantification of
the number of BrdU-positive cells in S-phase. This experiment was conducted twice (a
representative experiment is shown). (C) Western blot of S100 lysates from control and
FEN1-depleted HeLa cells. CycA (Cyclophilin A) (lower panel) is shown as a loading
control. (D) SV40 Large T dependent in vitro DNA replication assay was conducted
using lysates from control (shSCR) and FEN1-depleted (shFEN3) HeLa cells as
described in the methods. The assay was stopped at indicated times and the replication
products were separated via gel electrophoresis. The replication products were detected
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via autoradiography (Autorad) and the input DNA was observed via ethidium bromide
(EtBr) staining. A representative experiment is shown. (E) Quantification of the
replication products at the indicated times. Two independent experiments were
conducted in duplicate and the average of the four experiments is shown. The error bars
represent SEM.
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Figure 3.4. FEN1 mutants interact with TRF2 and localize to the telomere.
(A) FEN1 mutants interact with TRF2. 293T cells transfected with flag-tagged mouse
wildtype FEN1 (mWT) or FEN1 mutants, ΔP, ΔPΔC and mED and subjected to
immunoprecipitation (IP) with an anti-TRF2 antibody as described in the methods. The
presence of TRF2 and the FEN1 mutants were detected by immunoblot (IB) using antiTRF2 and anti-Flag antibodies, respectively. The input lane indicates 10% of total
protein used per immunoprecipitation. (B) FEN1 mutants localize to the telomere.
Representative ChIP analysis of 293T cells (Ctrl) or 293T cells transfected with wildtype
FEN1 (hWT or mWT) or FEN1 mutants (ΔP, ΔPΔC and mED), subjected to
immunoprecipitation with the M2 flag antibody. Precipitated DNA was probed for the
presence of telomeric sequences as described in the methods. The inputs indicate 0.1%
and 0.2% of the total protein extract. (C) Quantification of the representative ChIP assay.
Percent of telomere pulldown was calculated using input DNA and the control pulldown
percentage was set to 1.
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Figure 3.5. The gap endonuclease activity of FEN1 is essential for its function at the
telomere.
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(A) Chromosome Orientation – Fluorescent in situ hybridization (CO-FISH) schematic.
Newly synthesized DNA strands incorporate BrdU and BrdC. UV and ExoIII treatment
results in degradation of newly synthesized DNA containing BrdU and BrdC, and the
template strands are hybridized with Cy3-[CCCTAA]3 (red, lagging strand) and FLU[TTAGGG]3 (green, leading strand) probes. (B) Western blot of FEN1 (upper panel)
from BJ fibroblasts infected with shSCR and shFEN3. β-Actin (lower panel) is shown as
a loading control. (C) Timeline of experimental procedure given in days. (D)
Representative CO-FISH of metaphases from BJ fibroblasts expressing shSCR or
shFEN3 and the indicated FEN1 proteins. Ctrl refers to cells that do not express
exogenous FEN1 protein. Color schemes are as described in (A). DNA was stained with
4’,6-diamidino-2-phenylindole (DAPI; blue).
The arrowheads indicate missing
telomeres. (E) Quantification of sister telomere losses on metaphase chromosomes
following depletion of endogenous FEN1 and expression of the indicated FEN1 protein,
depicted as percentage of chromosomes with missing leading and lagging strand
telomeres. A minimum of 60 metaphases from two independent experiments was
analyzed per treatment in a blinded fashion and an average of the two experiments is
shown (*P<0.0001). The error bars represent SEM.
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Abstract
Abrogation of telomere stability through loss of function mutations in telomere binding
proteins contributes to genomic instability and cancer progression. Recently, Flap
endonuclease 1 (FEN1) was shown to contribute to telomere stability in human cells that
had not yet activated a telomere maintenance mechanism, suggesting that abrogation of
FEN1 function influences the transformation process by compromising telomere stability
and driving genomic instability. Here, we analyze the telomeres in human cancer cells
following FEN1 depletion. We show that FEN1 is required for telomere stability in cells
that rely on the alternative lengthening of telomere (ALT) mechanism.

Indeed, FEN1

depletion resulted in telomere dysfunction, characterized by formation of telomere
dysfunction-induced foci (TIFs) and end-to-end fusions in ALT-positive cells.

In

contrast, no telomere phenotype was observed in telomerase-positive cells upon FEN1
depletion, suggesting that ongoing telomerase activity protected telomeres.

In

consonance with this, we found that expression of the catalytic component of telomerase
(hTERT) but not an inactive allele rescued telomere dysfunction upon FEN1 depletion in
ALT cells. Our data suggests that mutations that arise in FEN1 impact telomere stability
and genome fidelity by promoting telomere fusions and anaphase-bridge-breakage cycles
that further drive genome instability and thereby contribute to the transformation process.

Results and Discussion
Loss of function mutations in genes involved in detection, signaling, and repair of DNA
damage correlate with increased genomic instability and cancer incidence. Proper
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maintenance of telomere function is critical to genomic stability. As a functional DNAprotein complex, the telomere distinguishes the end of a chromosome from a bona fide
double strand break. Destabilization of telomere structure compromises its function and
renders it susceptible to the actions of the DNA repair machinery, often leading to
chromosome end-to-end fusions (de Lange, 2005). Telomeric fusions result in anaphase
bridge-breakage cycles, which contribute to genomic instability and drives the
transformation process (Artandi & DePinho, 2000).

The telomere consists of repetitive double and single stranded DNA (TTAGGG) and six
core proteins referred to as Shelterin (or Telosome) (de Lange, 2005; Liu et al., 2004) that
together shield the telomere from the DNA repair machinery. In addition to the Shelterin
components, a growing list of accessory proteins localize to the telomere and play
essential roles in telomere maintenance (Blasco, 2005). For example, ATM, WRN and
Ku influence telomere stability where mutation and/or depletion of these proteins result
in cancer syndromes (Blasco, 2005). Together these data underscore the importance of
these DNA replication and repair proteins in telomere maintenance and high fidelity
maintenance of the genome.

Recently, we demonstrated that Flap endonuclease 1 (FEN1) is a telomere binding
protein that plays an important role in maintaining telomere stability in human cells
(Saharia et al., 2008). RNAi-directed depletion of FEN1 led to sister telomere loss (STL)
that was restricted to telomeres replicated by lagging strand DNA synthesis (Saharia et
al., 2008). FEN1 is a multifunctional nuclease that participates in replication (Li et al.,
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1995), long-patch base excision repair (Prasad et al., 2000), homologous recombination
(Kikuchi et al., 2005), re-initiation of stalled replication forks and DNA degradation in
apoptotic cells (Zheng et al., 2007; Zheng et al., 2005). Work in yeast revealed that
disruption of the FEN1 homolog, Rad27, results in a DNA mutator phenotype and
telomere dysfunction (Parenteau & Wellinger, 1999; Parenteau & Wellinger, 2002;
Tishkoff et al., 1997).

Similarly, mice heterozygotic for FEN1 display a mutator

phenotype and are predisposed to develop neoplasias (Kucherlapati et al., 2007). Given
that the initiation and development of cancer results in part from accumulation of genetic
instability and that telomere dysfunction can contribute to this instability, abrogation
and/or mutation of genes such as FEN1 may contribute to this process. Indeed, such a
role for FEN1 was suggested by a recent report demonstrating that knock-in of a FEN1
mutant gene identified in human cancers resulted in cancer predisposition in a murine
model (Zheng et al., 2007). Specifically, when a FEN1 mutant that abrogates a repair
function known as the gap endonuclease (GEN) activity was knocked into the analogous
murine locus, animals developed several pathologies including lung tumors (Zheng et al.,
2007). This observation together with our previous findings, raise the possibility that
FEN1 depletion (and/or mutation) impacts genomic stability by abrogating telomere
stability and in this way contributes to the transformation process.

FEN1 is required for telomere stability in ALT cells. In previous work we found that
FEN1 depletion in somatic cells that have not activated a telomere maintenance
mechanism led to telomere dysfunction that was compensated for by ectopic expression
of the catalytic component of telomerase (hTERT) (Saharia et al., 2008).
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This

observation raised the possibility that FEN1 depletion or mutation might impact telomere
stability in transformed cells that utilized the ALT mechanism of telomere maintenance.
Thus, we investigated whether FEN1 depletion affected telomere stability in a human
osteosarcoma cell line (U2OS) that is telomerase negative and maintains its telomeres via
the recombination-dependent ALT mechanism (Bryan et al., 1997).

To control for

possible off-target effects associated with RNAi, we utilized two independent lentiviral
constructs expressing short hairpin RNAs (shRNA) targeted to FEN1’s coding region and
3’ untranslated region (shFEN and shFEN3, respectively). In addition, a short hairpin
consisting of a scrambled sequence (shSCR) was also introduced into these cells and
functioned as a negative control.

Following transduction, FEN1 protein expression was determined by Western blot
analysis.

Expression of the two hairpins (shFEN and shFEN3) led to a significant

reduction in FEN1 protein levels (Figure 4.1A). To determine the effect of FEN1
depletion on telomere stability, metaphase spreads were prepared and analyzed for
telomere dysfunction. Metaphases were labeled using fluorescent in situ hybridization
(FISH) with telomere (red) and centromere (green) probes and analyzed (Figure 4.1B).
Analysis of metaphase spreads revealed that FEN1 depletion led to telomere dysfunction
characterized by chromosomal end-to-end fusions that retained telomeric sequences at the
fusion points (Figure 4.1B). U2OS cells expressing shSCR displayed 0.1 telomere fusion
events per cell. In contrast, FEN1 depletion resulted in a significant increase in the
number of telomere fusions observed in U2OS cells to 0.33 (P<0.001) and 0.38 (P<0.01)
events in the shFEN and shFEN3 expressing cells, respectively (Figure 4.1C).
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Moreover, the percentage of cells having one or more fusion events increased from 6.7%
in the shSCR expressing cells to 27% and 33%, respectively in the shFEN and shFEN3
expressing cells.

The telomeric impact of FEN1 depletion was not unique to U2OS cells.

Indeed,

depletion of FEN1 in a second ALT cell line GM847 (Figure 4.1A) also resulted in a
significant increase in telomere dysfunction (Figure 4.1B-E). GM847 cells infected with
a control virus displayed 0.07 telomeric fusions. In contrast, expression of shFEN and
shFEN3 led to 0.8 and 0.57 telomeric fusions, respectively with 50-60% of the
metaphases analyzed displaying one or more telomeric fusion (P<0.0001; Figure 4.1C).

Several groups have demonstrated that DNA damage foci referred to as telomere
dysfunction-induced foci (TIFs) are readily detectable when telomere stability is
compromised (d'Adda di Fagagna et al., 2003; Takai et al., 2003). Therefore, to confirm
the presence of telomere dysfunction upon FEN1 depletion, we examined cells for the
presence of γH2AX foci at telomeres. As expected, we found that FEN1 depletion led to
an increase in TIFs (Figures 1D and 1E). In GM847 cells infected with a control hairpin,
we noted that 27.9% of the cells had greater than 5 TIFs per cell, whereas upon infection
with shFEN, the number of cells with greater than 5 TIFs increased to 78.2% (Figure
4.1E). Together these data demonstrate that FEN1 contributes to telomere stability in
immortal cells and that its depletion leads to telomere dysfunction in cells that maintain
their telomeres via the ALT mechanism.
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FEN1 depletion in telomerase positive cells does not impact telomere stability.
Human cancer cells maintain stable telomere lengths through activation of either ALT or
the telomerase enzyme. Above we demonstrate that FEN1 depletion leads to telomeric
fusions in ALT cells. In addition, in a previous report we demonstrated that FEN1
depletion in mortal human fibroblasts led to sister telomere losses (STL) that were
rescued by expression of catalytically active telomerase. Together, these data argue that
tumor cells that have activated telomerase would be insensitive to FEN1 depletion. To
test this hypothesis directly, we examined how FEN1 depletion impacted telomere
stability in telomerase-positive cells. HeLa cells, a cervical cancer cell line that utilizes
telomerase for telomere maintenance, were transduced with viral vectors expressing
shSCR, shFEN, or shFEN3. Upon FEN1 depletion (Figure 4.2A), cells were analyzed
for telomeric fusions as described above. As expected, depletion of FEN1 did not result
in telomeric fusions (Figure 4.2B and 4.2C). Similar results were observed in a second
telomerase positive ovarian cancer cell line, 36M (Figure 4.2). These results indicate that
cells that utilize endogenous telomerase for telomere maintenance are insensitive to
FEN1 depletion at the telomere.

Catalytically active telomerase rescues FEN1 depletion at the telomeres. Depletion of
FEN1 in cells that maintain stable telomeres via the ALT mechanism resulted in telomere
dysfunction. In contrast, telomere stability was unperturbed in telomerase-positive cells
following FEN1 depletion. These results were reminiscent of our earlier findings that
telomerase rescued sister telomere loss in cell lines that had not yet activated a telomere
maintenance program (Saharia et al., 2008). To determine whether the catalytic activity
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of telomerase was required to protect telomeres in cells that utilized the ALT mechanism,
we expressed the catalytic component of telomerase (hTERT) in GM847 cells (GM847hTERT) (Figure 4.3A) (Hahn et al., 1999).

Expression of hTERT reconstitutes

telomerase activity in these cells, leading to lengthening of the shortest telomeres
(Grobelny et al., 2001; Hemann et al., 2001; Perrem et al., 2001; Teixeira et al., 2004).

Introduction of shRNA constructs targeting FEN1 into GM847-hTERT cells resulted in a
significant reduction in protein expression (Figure 4.3B). Analysis of metaphase spreads
from cells expressing the FEN1 hairpins compared to those expressing a control hairpin
did not reveal an increase in telomere dysfunction (Figure 4.3C). To determine whether
it was the telomere extension activity of telomerase that compensated for FEN1 depletion
at the telomeres as suggested by our earlier work, we utilized a catalytically inactive,
dominant negative allele of hTERT (DN-hTERT) (Figure 4.3A). This allele was chosen
because previous work demonstrated that it had no impact on telomere stability in
GM847 cells (Stewart et al., 2002). In contrast to that observed in GM847-hTERT cells,
FEN1 depletion in GM847-DN-hTERT cells resulted in increased telomeric fusions
(Figure 4.3B and 4.3C). FEN1 depletion increased the number of telomere fusion events
per cell from 0.15 events in control cells, to 0.55 and 0.53 in cells expressing the two
hairpins against FEN1 (P<0.01; Figure 4.3C). There was also a large increase in the
percentage of metaphases possessing one or more fusions (46% versus 13% in the control
cells). The inability of DN-hTERT to rescue FEN1 depletion at the telomere indicates
that the catalytic activity of telomerase is important for this rescue and suggests that
telomeric extension by telomerase is important in the absence of FEN1.
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FEN1 is a structure specific endonuclease that acts in DNA replication and repair. Here,
we assessed the role of FEN1 in the context of telomere stability.

We found that

depletion of FEN1 in cancer cells that maintain their telomeres via the ALT mechanism
results in telomere dysfunction characterized by increases in the number of TIFs and
telomeric fusions. In contrast, FEN1 depletion did not lead to telomere dysfunction in
telomerase positive cells. Telomere fusions observed in ALT cells were rescued by the
expression of catalytically active telomerase but not a catalytically dead enzyme. Given
our earlier work demonstrating that single telomeres were lost in pre-crisis human cells
upon FEN1 depletion (Saharia et al., 2008) this result suggests that the ability of
telomerase to elongate the shortest telomeres was protective. Together these results
suggest that abrogation of FEN1 function in telomerase-negative tumor cells results in
increased genomic instability by compromising telomere stability that may contribute to
tumor progression.

DNA replication is a challenging cellular event that is prone to errors that can result in
loss of genomic fidelity.

Sequences that offer significant challenges to the DNA

replication machinery are repetitive DNA sequences, particularly those containing
triplicate repeats (Fouche et al., 2006), which hinder replication fork progression.
Therefore, it is not surprising that the repetitive G-rich nature of the telomere presents a
challenging template for the replication machinery (Gilson & Geli, 2007). Indeed, this
has been underscored by in vitro DNA replication systems that have shown that
replication of telomeric sequences is less efficient than randomized sequences due to a
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significant increase in stalled DNA replication forks within telomeric sequences (Ohki &
Ishikawa, 2004).

For these reasons, the impact of loss of function mutations in genes

that facilitate replication fork progression and restart would be expected to have a
profound impact at the telomere. Indeed this has been observed with the Werner protein
(Crabbe et al., 2004) as well as FEN1 (this study). FEN1 functions with the Werner
protein to process branch migrating structures that resemble stalled replication forks
(Sharma et al., 2004). Therefore, given that unresolved stalled replication forks lead to
DNA double strand breaks (Branzei & Foiani, 2005), loss of Werner or FEN1 activity
would be expected to result in telomere loss and subsequent end-to-end fusions.

Our previous work demonstrated that FEN1 depletion led to sister telomere losses but no
significant telomeric fusions were observed (Saharia et al., 2008). Why then do we
observe telomeric fusions in cells that utilize the ALT mechanism? Telomeres within
ALT cells are in a constant state of flux, where they undergo rapid elongation and
shortening (Londono-Vallejo et al., 2004).

This dynamic fluctuation results in

chromosome ends with extremely short telomeres that are unlikely to adequately protect
telomere ends from recognition by DNA damage surveillance mechanisms. As a result,
telomeres within ALT cells are recognized as DNA damage, as evidenced by the
presence of TIFs or γH2AX foci at many telomeres (Figure 4.1D and 4.1E, shSCR)
(Nabetani et al., 2004). Depletion of FEN1 appears to exacerbate telomere dysfunction
by producing signal free ends in fibroblasts (Saharia et al., 2008) and increasing the
number of TIFs in ALT cells

(Figure 4.1D and 4.1E), thus leading to additional

substrates capable of participating in end-to-end fusions. Because telomerase acts on the
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shortest telomeres (Forstemann et al., 2000; Marcand et al., 1999; Ouellette et al., 2000)
it would be recruited to those chromosome ends that experienced a catastrophic loss due
to a stalled and unresolved replication fork or failure to cap the telomere. Telomerase
could then extend the short telomeres, stabilizing them and rescuing telomere
dysfunction. These studies suggest that FEN1 mutation contributes to the transformation
process by increasing genomic instability through telomere loss and subsequent end-toend fusions. Further, abrogation of FEN1 function in tumor cells that do not utilize
telomerase may result in additional genomic instability leading to progression of the
neoplastic state.
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FIGURE 4.1. FEN1 depletion leads to telomere dysfunction in ALT cells.
(A) Two independent shRNAs targeting FEN1 (shFEN and shFEN3) and one consisting
of a scrambled sequence (shSCR) were introduced by lentiviral infection into GM847 and
U2OS cells and FEN1 expression was determined by western blot analysis. (B)
Representative metaphases from GM847 and U2OS cells following indicated shRNA
expression. FISH analysis was conducted using Cy3-labeled TTAGGG probes (in red)
and FITC-labeled centromere probes (in green). DNA was stained using 4’,6-diamidino2-phenylindole (DAPI; in blue). The lower panel shows a higher magnification image of
the metaphase chromosomes. (C) Quantification of telomere fusion events observed after
indicated treatments of GM847 (blue bars) and U2OS (white bars) cells. A minimum of
60 metaphases was analyzed per treatment in a blinded fashion. Statistical analysis was
conducted using the Wilcoxon Two-Sample Test. (*P<0.001; #P<0.01). (D) FEN1
depletion increases TIF formation in GM847 cells. Immunofluorescence was conducted
using anti-TRF2 (green: Santa Cruz, CA, USA; H-300), anti-γH2AX (red: Upstate, NY,
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USA; 05-636) and DAPI (blue). Confocal images were acquired on a Zeiss Axiovert 200
microscope. (E) TIF quantification in GM847 cells. A minimum of a 100 cells was
counted for each condition and the average for two experiments is presented. Cell culture,
western blot analysis, viral constructs and production as well as metaphase preparation
and statistical analyses were as previously described (Saharia et al., 2008; Stewart et al.,
2003; Stewart et al., 2002).
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FIGURE 4.2. FEN1 is not essential for telomere stability in telomerase positive cells.
(A) Western blot analysis reveals that introduction of two different shRNAs targeted to
FEN1 leads to reduction in FEN1 protein levels in HeLa and 36M cells. (B)
Representative metaphases from HeLa and 36M cells following shRNA expression. (C)
Quantification of telomere fusion events observed following shRNA expression in HeLa
(white bars) and 36M (black bars) cells. A minimum of 60 metaphases was analyzed per
treatment in a blinded fashion. Statistical analysis was conducted using the Wilcoxon
Two-Sample Test.
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FIGURE 4.3. Catalytically active telomerase rescues telomere instability upon FEN1
depletion.
(A) Reverse transcriptase (RT) PCR demonstrating exogenous expression of the catalytic
component of telomerase (hTERT), dominant negative hTERT (DN- hTERT), or
uninfected (CTRL). RNA isolation, PCR and primers were as previously described
(Hahn et al., 1999). (B) Western blot analysis reveals that introduction of two different
shRNAs targeted to FEN1 leads to reduction in FEN1 protein levels in hTERT and DNhTERT cells. (C) Quantification of telomere fusion events following shRNA expression
in hTERT (white bars) and DN-hTERT (black bars) cells. A minimum of 60 metaphases
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was analyzed per treatment in a blinded fashion. Statistical analysis was conducted using
the Wilcoxon Two-Sample Test (*P<0.01).
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CHAPTER 5:
CONCLUSIONS AND FUTURE DIRECTIONS
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5.1 Summary
Telomeres need to be replicated with high fidelity to ensure genomic stability.
Lack of fidelity will lead to loss of telomere integrity, its recognition as a DNA double
strand break, end-to-end fusions, fusion-breakage-bridge cycles and ultimately to
genomic instability. Considering that genomic instability is a driving force for cancer,
high fidelity telomere replication is critical for tumor suppression. Flap Endonuclease 1
(FEN1) is a structure specific metallonuclease that performs several roles in DNA
metabolism. In Chapters 2, 3 and 4 I demonstrate that FEN1 is critical for telomere
stability. FEN1 depletion led to telomere dysfunction characterized by recognition of the
telomeres as DNA double strand breaks (DSBs), activation of a DNA damage response
(DDR) at telomeres, loss of single sister telomeres (STLs) in primary fibroblasts and
telomere fusions in ALT-positive cancer cells. Despite the impact on telomeres, no
significant defects were observed on DNA replication and cell cycle progression,
indicating a telomere specific role for FEN1 that is independent of its role in Okazaki
fragment maturation. The work presented in the preceding chapters thus allows us to
postulate that FEN1 contributes to telomere stability by ensuring the efficient resolution
of stalled replication forks at mammalian telomeres. The following sections underscore
the significance of this work and how it contributes our understanding of telomere
biology, genome stability and tumorigenesis.
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5.2 FEN1 in DNA Replication and Repair
FEN1 is an important DNA replication and repair protein involved in genome
maintenance. In an in vitro assay utilizing purified proteins, FEN1 was identified as one
of the ten essential components required for DNA replication [1]. However, deletion of
the FEN1 gene in several different organisms does not inhibit DNA replication, which
continues with relatively minor defects. Indeed, rad27Δ in S. cereviseae, rad2Δ in S.
pombe, and FEN1 deletion in chicken DT-40 cells does not inhibit bulk DNA replication
[2-4]. However, deletion of mammalian FEN1 leads to early embryonic lethality in mice
[5], suggesting a critical function for FEN1 in mammalian cells. My work demonstrates
that FEN1 depletion in human cells does not affect DNA replication in vitro or
progression through S-phase (Chapter 3). Furthermore, FEN1 depletion, in the absence
of telomere dysfunction, does not lead to genomic instability in primary fibroblasts
(Chapter 2) indicating that another nuclease, such as Dna2 or Exo1, is able to compensate
for FEN1 depletion during Okazaki fragment maturation [6-10]. The aforementioned
studies utilized complete gene knockouts to investigate FEN1 function whereas my work
in human cells has utilized virus-based shRNA technology to deplete FEN1 from the
cells, which does not completely eliminate the endogenous protein. Therefore, it is
possible that the small amount of FEN1 remaining is sufficient for uninhibited DNA
replication. However, FEN1 depletion does affect telomere stability, indicating that there
is functional loss of this protein. Only construction of human cells with FEN1 deletion
from the genomic locus will conclusively address whether it is essential for human DNA
replication.
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Cytogenetic analysis upon FEN1 depletion in human telomerase-positive cells,
lacking telomere dysfunction, revealed few aberrations indicating an absence of genomic
instability. However, this is a macro view and therefore only one facet of genomic
instability. Work in yeast and in mice show that FEN1 also plays a critical role in
maintaining stable microsatellite and triplet repeats in the genome [11, 12].

This

observation was species-specific, as the same was not seen in drosophila upon FEN1
deletion [13, 14]. Additionally, a recent study in human cells observed no expansion of
the CAG Huntington’s locus upon FEN1 depletion [15], indicating that human cells do
not replicate the genomic instability phenotypes observed in other organisms. Together,
these studies support our observations on the lack of genomic instability in telomerasepositive cells upon FEN1 depletion. However, a more cautious analysis of the different
micro-satellite, mini-satellite and rDNA repeat regions via Southern analysis of genomic
DNA from FEN1-depleted human cells [15] needs to be conducted to investigate genome
stability.

Although our data indicates that FEN1 is not essential for Okazaki
fragment processing in human cells, work from Chapter 3 demonstrates a significant
novel role for FEN1 in DNA repair through the re-initiation of stalled replication forks.
This work supports recent studies suggesting that FEN1 plays a role in the re-initiation of
stalled replication forks [16, 17]. It was previously shown that treatment of cells with
cisplatin or mitomycin C (MMC), DNA cross-linkers that stall replication forks,
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increased FEN1 association with WRN, a RecQ helicase, and led to the co-localization of
this complex to the stalled forks [16]. Stalled replication forks can be converted to
Holliday junctions (HJs) through fork regression, branch migration and the annealing of
nascent DNA strands [18]. Together the WRN-FEN1 complex is able to process these
branch migrating structures known as “chickenfoot” structures [16, 18]. FEN1 also
possesses a gap endonuclease (GEN) activity, which can be stimulated by WRN and
enhances the cleavage and resolution of chickenfoot and bubble-shaped DNA structures
[17]. One can speculate that the telomeric lagging strand forms a putative G-quadruplex
(G4) lesion, stalls the moving replication fork that regresses and forms chickenfoot
structures, which can now be processed by the WRN-FEN1 complex to re-initiate the
stalled replication fork. Furthermore, evidence from E.coli DNA replication and repair
demonstrates that upon stalling of a replication fork, the RecQ DNA helicase and RecJ, a
5’ to 3’ exonuclease, can process the regressed replication fork intermediate to reinitiate
replication [19-21]. The mammalian homologs of the RecQ-RecJ proteins that participate
in the processing of stalled replication forks have not yet been identified. However, we
could reason that such function could be assumed by a RecQ helicase such as WRN or
BLM and a RecJ nuclease, FEN1. This hypothesis could be tested by gene replacement
experiments of the E. coli genes with their mammalian counterparts.

Though the above studies suggest a role for FEN1 in the re-initiation of stalled
replication forks, this work is the first to conclusively demonstrate it. FEN1’s role in fork
re-initiation suggests that its depletion should sensitize cells to replication stress-causing
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reagents such as HU, mitomycin C (MMC) and cisplatin. Indeed, recent work has
demonstrated that FEN1-depleted cancer cells are sensitive to cisplatin [22].

Our

knowledge of FEN1 function in the re-initiation of stalled replication forks is still in its
nascent stages and the experiments suggested herein will give us a greater understanding
of its role in the re-initiation of stalled replication forks and at telomeres.

5.3 Telomere Replication: FEN1 at the ends
Replication of telomeres inherently possesses several “high risk” elements
(Figure 1.4). Telomeric DNA consists of a highly repetitive sequence and has a greater
probability of forming secondary structures. In addition, telomeres are replicated from a
single unidirectional fork and remain unreplicated if the fork collapses. The intricacies in
telomere replication are compounded by the presence of the T-loop, which needs to be
resolved before replication and reformed post-replication.

To address these unique

challenges the DNA replication machinery undertakes specialized action for efficient
telomere replication and stability [23, 24].

Indeed, several studies have indicated that telomere replication and stability is
influenced by an increasing number of DDR proteins. Recent work demonstrates that
during replication of human telomeres the ATR-dependent DDR machinery is recruited
together with the DNA replication machinery [25].

The ATR-dependent repair

machinery is postulated to be present at the telomere in response to stalled replication
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forks, leading to their resolution and efficient telomere replication. FEN1 localizes to the
telomere during telomere replication [25]. It is possible that FEN1 impacts telomere
stability in two ways that are not mutually exclusive. It could be recruited to the telomere
in S-phase for DNA replication with PCNA and the replication machinery for the
processing of Okazaki fragments [26]. Alternatively, it could engage in the efficient
resolution of stalled replication forks with the ATR-dependent repair machinery [16, 17].
Our data do not negate the possibility of either scenario of FEN1 function at the telomere.
However, they do demonstrate that the FEN1 function in the re-initiation of stalled
replication forks is essential to telomere stability whereas FEN1’s ability to interact with
PCNA and process Okazaki fragments is dispensable for telomere stability.

Although the results presented suggest the presence of stalled replication forks at
human telomeres after FEN1 depletion, this has not been directly shown. Direct evidence
demonstrating the presence of stalled replication forks upon FEN1 depletion in human
cells has been difficult to obtain due to technical hurdles. Below, I have outlined some of
the techniques that may be utilized to investigate the presence of stalled replication forks
at telomeres upon FEN1 depletion.

First, 2D gel electrophoresis of the replication

intermediates of human telomeres would identify the presence of stalled forks, if present,
upon FEN1 depletion. However, this approach is technically challenging and given the
stochastic nature of the observed phenotype, would make the analysis extremely difficult.
Alternatively, taking advantage of the model organism, S. pombe, where 2D gel
electrophoresis of telomere replication intermediates is simpler due to fewer
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chromosomes [27], we can investigate whether rad2Δ (the FEN1 homolog) cells have
stalled replication forks at their telomeres. Given that human FEN1 can compensate for
its yeast homolog [28], this technique will also provide a clear way to investigate the role
of certain mutations in telomere replication.

Thirdly, the most direct method to investigate the presence of stalled replication
forks at human telomeres upon FEN1 depletion is through single molecule analysis of
replicating DNA (SMARD) [29]. This technique double labels replicating telomeres with
two BrdU analogs that are temporally separated, allowing the direct measurement of the
number of stalled replication forks per number of replicating telomeres.

SMARD

analysis affords us the opportunity to investigate the role of FEN1 in the re-initiation of
stalled replication forks both at the telomere and away from it [29]. Finally, a simpler but
indirect method for investigating the presence of stalled replication forks is to identify
ATR, ATRIP or phosphorylated-RPA foci at telomeric DNA [29, 30]. If FEN1 depletion
leads to increased numbers of stalled replication forks at telomeres, I would predict
increased localization of ATR-dependent DDR machinery there.

The experiments

outlined above will provide further evidence of stalled replication forks at telomeres upon
FEN1 depletion.

Recently, telomeres have also been identified as fragile sites [29].

This result

suggests that fragile site expression (fragile sites are said to be ‘expressed’ when they
exhibit cytogenetic abnormalities such as gaps and breaks on metaphase chromosomes) at
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telomeres might contribute to the inefficient replication of telomeres and lead to loss of
single sister telomeres (STLs). Fragile sites are usually expressed upon the induction of
replication stress and in the absence of certain proteins that help maintain those sites,
such as BLM [31]. Considering the complexity of telomere replication and the stalling of
replication forks traversing the telomere, I propose that the telomere provides a natural
form of replication stress. My results indicate that FEN1 depletion leads to an increase in
replication stress at telomeres, suggesting a role for it suppressing fragile site expression
at telomeres. To investigate FEN1’s role in the maintenance of telomere fragile sites, we
could monitor fragile site expression at telomeres (presence of abnormal telomere
signals) in FEN-1 depleted cells. Additionally, it will be interesting to subject FEN1depleted cells to further replication stress such as exposure to low levels of aphidicolin,
an inhibitor of DNA polymerases α and δ, and analyze fragile site expression on
metaphase chromosomes, both at and away from the telomere. If FEN1 were involved in
the fragile site maintenance at the telomere and across the genome, we would expect an
increase in fragile site expression. Alternatively, the increase in fragile telomeres may be
a secondary effect of FEN1 depletion and we would then expect to see no modulation of
fragile site expression on a genomic scale upon inducing replication stress.

5.4 FEN1, TRF2 and the RecQ helicases, BLM and WRN
Interestingly, expression of a C-terminal deletion mutant of FEN1, which
abolishes interaction with WRN [32], cannot rescue FEN1 depletion at the telomeres in
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non-immortal cells. The C-terminus is also essential for its interaction with the BLM
protein [32] and TRF2 (Chapter 2). Given the importance of FEN1’s C-terminus for
telomere function and its ability to interact with BLM, WRN and TRF2, it is critical to
determine which of these proteins recruits FEN1 to the telomere. One hypothesis is that
all these proteins, in conjunction with other unidentified players, mediate telomere
replication and the following experiments will allow us to investigate this.

Similar to WRN, BLM is able to unwind G4 DNA, is critical for the re-initiation
of stalled replication forks and has recently been shown to be important for the efficient
replication of telomeres [29, 33-35]. The BLM-FEN1 complex may play a role similar to
the WRN-FEN1 complex in alleviating replication stress during telomere replication.
Therefore, BLM may be able to partially compensate for WRN loss at the telomeres.
Deletion of Blm, similar to Wrn deletion, accentuates the pathology of later generation
telomerase RNA component (mTERC) knockout mice indicating a functional role for
BLM at mammalian telomeres [36].

It is of interest to investigate whether BLM

deficiency has a similar phenotype to the FEN1 and WRN deficiency in human cells, i.e.,
loss of single sister telomeres specifically from the lagging strand. Any compensation by
BLM for WRN can be investigated through epistasis analysis by the simultaneous
depletion of the two proteins. If BLM partially compensates for WRN depletion at the
telomere, simultaneous loss will lead to an additive effect on telomere dysfunction.
Given that FEN1 may also be recruited to the telomeres by TRF2 [37, 38], RecQ
helicase-independent function of FEN1 at the telomere may be investigated through
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similar epistasis analyses with the simultaneous depletion of FEN1 or BLM or both in
WRN-deficient cells. An increase in telomere dysfunction upon FEN1 depletion in cells
without both BLM and WRN would suggest a role for FEN1 in telomere maintenance
independent of the two RecQ helicases.

TRF2’s interaction with FEN1 [37, 38] may directly engage the latter to actively
repair and/or replicate telomeres. Interestingly, TRF2 also interacts with and stimulates
the activities of WRN and BLM RecQ helicases [39-41]. This raises the possibility that
these proteins act concordantly to enhance replication and repair of telomeres.
Interestingly, a recent study demonstrated that TRF2 increases branch migration of HJ
intermediates, suggesting that this promotes formation of chickenfoot structures in the
context of a stalled replication fork at telomeres [42].

TRF2, which binds these

chickenfoot structures, may engage the WRN-FEN1 complex to act upon and resolve
them [16].

In effect, TRF2 could enable this complex to efficiently restart stalled

replication forks at telomeres.

5.5 FEN1: A Tumor Suppressor
Several reports have demonstrated a significant role for FEN1 in oncogenesis.
FEN1 overexpression has been associated with human lung, prostate, brain and breast
cancer [22, 43-46]. Strikingly, FEN1 haploinsufficiency increases cancer incidence in
mice with a heterozygous Adenomatous polyposis coli (APC) background [47, 48].
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Interestingly, mutations have also been detected in a variety of human tumors that abolish
the GEN and EXO, but not the FEN, activities of FEN1 [49]. Furthermore, when Shen
and colleagues knocked-in one of the detected E160D (mED) human cancer mutations
into mice, the transgenic animals spontaneously developed tumors indicating that FEN1
is a tumor suppressor gene [49]. A similar study conducted on a different strain of mice
with the same mED mutation in FEN1 revealed a different spectrum of cancers [50].
Although in the first study [49], tumorgenesis was attributed to incomplete DNA
fragmentation during apoptosis, an alternate hypothesis for this phenotype may also been
proposed [50]. Our results with the FEN1 mED mutation (Chapter 4) suggest that the
increased genomic instability and cancer incidence in mice with this mutation is caused
by telomere dysfunction. Indeed, murine cells expressing the mED mutant have telomere
dysfunction evidenced by telomere end-to-end fusions [51]. Additionally, comparative
genomic hybridization of the resulting tumors in the E160D mice showed genomic
instability with changes in chromosome copy number, chromosomal rearrangements,
gains and losses [50]. Telomere-dysfunction induced genomic instability is a known
driving force for tumorigenesis [52-54], suggesting a similar mode of transformation in
the E160D mutant mice. However, evidence for telomere dysfunction in the FEN1 mED
murine cells is not conclusive and further work is required to demonstrate the nuclease
deficiency associated with the FEN1 E160D mutation and its effect on telomere stability
in mice. These studies will allow us to further investigate the effect of FEN1 E160D
mutation on genomic stability and cancer incidence in both the mouse and human.
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As described above, FEN1 is a tumor suppressor. Conversely, FEN1 depletion
and/or inhibition kills human colorectal cancer cells that have a Rad54B deletion [55],
raising the possible therapeutic utility of FEN1 inhibition. The study demonstrates that
cancer cells with a Rad54B deletion have increased chromosomal instability and can be
effectively and selectively killed by depleting synthetic lethal genes such as FEN1 [55].
To this end, specific small molecule inhibitors of FEN1 have been identified and
characterized in mammalian cells, making FEN1 inhibition a distinct possibility for
cancer therapeutics [56, 57]. However, my data suggest that this approach be taken with
caution. Indeed, telomerase-positive tumor cells, which represent the vast majority of all
tumor cells do not appear to be affected by FEN1 depletion. Nonetheless, this approach
may have utility in telomerase-negative, ALT-positive tumor cells, which display
telomere dysfunction and cell death upon FEN1 depletion (Chapter 3).

5.6 Conclusions
High fidelity replication and maintenance of the genome is fundamental to the
preservation of life. Genome stability is intricately linked to the faithful maintenance of
telomere stability.

Telomere replication, an essential but relatively unexplored

component of telomere maintenance, is a complicated task. Telomere chromatin poses
several challenges to the moving replication fork causing natural stalling/pausing. For
these reasons, loss of function mutations or depletion of genes that facilitate replication
fork progression and restart would be expected to have a profound impact at the telomere.
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This thesis identifies complications associated with telomere replication and characterizes
one protein, FEN1, as a necessary component of the telomeric replication machinery.
The results presented herein demonstrate that FEN1 works in a complex with a RecQ
helicase (WRN, BLM or both) to efficiently resolve stalled replication forks at sites of
stalling. The inability to efficiently resolve stalled forks at the telomere leads to the
drastic loss of the distal end of the telomere causing telomere dysfunction. Therefore,
FEN1 mutation/depletion increases telomere dysfunction, leading to an increase in
genomic instability, a known driving force for cancer.

My model provides an

explanation for the increased cancer incidence observed in mice and humans with
mutations in the FEN1 gene. Conversely, telomere dysfunction and subsequent genomic
instability associated with FEN1 depletion/inhibition can be exploited to selectively
target telomerase-negative tumor cells harboring other critical mutations.
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